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Abstract 
Clinical diagnosis of vitamin B12/cobalt (Co) deficiency is difficult due to the 
unspecific nature of the clinical symptoms. The apparent increase in vitamin B12 
deficiency in New Zealand in the late 1990’s made it clear that health providers 
were very reliant on plasma reference ranges to diagnose deficiency. However, 
the lack of quantitative data of what these reference ranges represent in terms of 
supply of vitamin B12, has prevented a better understanding of the metabolism 
of vitamin B12 within sheep. This thesis describes the development of an 
experimental approach to measure vitamin B12 production and absorption in 
sheep. The model was then used to investigate whether the type of carbohydrate 
source affects vitamin B12 production and/or absorption.  
 
In the first trial (Chapter 4), an adaptation of the repletion technique of Suttle 
(1974) for copper was used. Previously vitamin B12 depleted sheep were 
maintained on a diet of 400 g DM meadow hay and 250 g DM crushed barley 
and which provided a daily intake of 0.03 mg Co. Sheep were intravenously 
infused with known quantities of vitamin B12 (0 – 200 nmol 
hydroxycobalamin/d) to determine whether a relationship exists between 
plasma vitamin B12 concentration and rate of entry of the vitamin into the 
bloodstream and to quantify the relationship. Eight ewes fitted with rumen and 
abomasal cannulae were used in a paired 4x4 Latin square design. Four levels of 
vitamin B12 were infused into the jugular vein for 4 d followed by recovery 
period of 17 d and the plasma responses measured during this period. Control 
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animals maintained relatively stable plasma levels while levels in treated 
animals rose sharply within 4 h after the start of infusion. The responses were 
proportional to infusion rate with a highly significant difference in 
concentrations observed between treatments (P<0.001). Appearance of vitamin 
B12 in the plasma was quantified by the relationship Y(pmol/l) = 238 + 102x0.74 
where x = infusion rate(nmol B12/d), R2 = 0.945. Plasma levels declined rapidly 
on cessation of infusion and had returned to original pre-treatment levels by the 
end of the recovery period.   
 
The second trial (Chapter 5) quantified plasma responses in relation to dietary 
Co supply to the rumen. The same eight rumen and abomasal cannulated ewes 
were used in a paired 4x4 Latin square with 4 levels of intra-ruminal Co 
infusion in amounts ranging from 0 – 1 mg Co/d as CoSO4, infused for 4 d 
followed by a 19 d recovery period. Plasma vitamin B12 response was measured 
as were concentration of vitamin B12 in abomasal digesta supernatant and 
digesta liquid flow, the latter using polyethylene glycol as liquid phase marker. 
Plasma concentration increased from approximately 300 pmol/l to 750 – 800 
pmol/l, peaking at day 5 after commencement of infusions. Control animals 
infused with water maintained base-line plasma vitamin B12 levels around 250 
pmol/l. Digesta liquid flow was estimated at 14.6 l/d. 
 
The results from Chapters 4 and 5 allowed estimates of vitamin B12 production 
and absorption. These results are discussed and efficiency of capture of Co into 
vitamin B12 from dietary Co intake was estimated to decrease from 8.4% to 
0.74% as Co intake increased from 0.03 to 1.11 mg Co/d. Absorption coefficient 
was estimated from the relationships between abomasal vitamin B12 flow and 
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plasma response. The absorption coefficient was calculated to increase from 7 to 
10% as abomasal vitamin B12 flow increased from 108 to 142 nmol/d.  
 
The current animal model was subsequently used in the final trial (Chapter 6) to 
investigate whether the type of carbohydrate supplied in the diet influences 
vitamin B12 production and absorption. The same eight ewes fitted with rumen 
and abomasal cannulae were used in a 2x4 cross-over design. Half of the ewes 
were maintained on the basal diet and crushed barley while, for the remainder, 
the barley was replaced by 250 g of fructose:sucrose in a 80:20 mix during a 7 d 
period of adaptation. While on their respective diets, both groups were then 
infused with 0.3 mg Co/d for 6 d, a level chosen to optimise plasma vitamin B12 
response. All ewes were then returned to the basal diet and barley for a 15 d 
recovery period after which treatments were reversed and the procedure 
repeated. Rumen pH, valeric, propionic, butyric, succinic, and acetic acid and 
ammonia concentrations were not significantly affected by diet. Digesta flow 
was 30% greater on a diet enriched with starch compared to sugar-enriched 
diet. There was an observed difference in vitamin B12 production. However there 
was no significant diet x time effect on plasma vitamin B12 concentration so any 
difference in production was negated by a difference in absorption. 
Carbohydrate supplied as water soluble carbohydrate or starch does not appear 
to influence plasma vitamin B12 concentration. 
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production efficiency, absorption efficiency 
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CHAPTER 1: Introduction 
The wasting disease or ill-thrift of a vitamin B12 deficient animal has been 
recognised since 1831 in parts of Scotland. However it was not until the early 
1930’s that such wasting was attributed to cobalt (Co) per se (Andrews, 1971). 
In New Zealand, cobalt (Co) deficiency has also been known regionally as ‘bush 
sickness’ in Nelson (Askew & Dixon, 1936), ‘Mairoa dopiness’ in the King 
Country (Wright & Taylor, 1931) and ‘Morton Main disease’ in Southland 
(Dixon, 1936).  
 
Cobalt is required in ‘trace’ quantities by ruminants for the synthesis of vitamin 
B12 and its analogues by rumen micro organisms (Marston, 1970; Kennedy et 
al., 1994; Clark, 1998; Underwood & Suttle, 1999). Since there are no known 
requirements for Co per se, the clinical signs of cobalt deficiency are ultimately 
a result of vitamin B12 deficiency. It was not until 1948, when two independent 
research groups, one in the United States and one in Great Britain (Andrews, 
1971) discovered vitamin B12, that an understanding of how Co eliminated the 
wasting of deficient animals was obtained.  
 
The problem of clinical diagnosis of Co/vitamin B12 deficiency is the unspecific 
nature of the clinical symptoms. While some symptoms such as poor thrift are 
also seen with other diseases, particularly parasitism and malnutrition, Co 
deficiency is typically described by loss of appetite, resulting in ill-thrift, 
anaemia, excessive lachrymation, increased perinatal mortality, decreased 
fertility and a fatty infiltration of the liver giving it a pale and friable 
appearance (Grace, 1994; Underwood & Suttle, 1999). The greatest 
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susceptibility is typically seen in lambs followed by mature sheep, calves and 
adult cattle (Andrews, 1971) . 
 
In the late 1990’s, the New Zealand farmer-funded Meat and Wool New 
Zealand Boards (then named Meat New Zealand and Woolpro respectively) 
were concerned with an apparent perceived increase in incidence of vitamin B12 
deficiency in the South Island of New Zealand. It became clear that farmers 
and veterinarians were very dependent on marginal reference ranges of 
vitamin B12 in plasma to diagnose deficiency without knowing exactly what 
these reference ranges represented in terms of supply of vitamin B12. The 
reference range was utilized by animal health laboratories derived from data 
collated by Clark et al. (1989). Generally, as long as plasma values were within 
the marginal range (336 – 500 pmol vitamin B12 /l for weaned lambs) 
supplementation was recommended. This was not the intended purpose of the 
reference curves which were meant to aid “veterinarian, consultants and 
farmers to make more informed decisions about cobalt supplementation” 
(Clark & Wright, 2005) rather than an absolute supplementation range. No 
knowledge exists on how much vitamin B12 needs to be absorbed to maintain 
plasma levels and how variable individual rates of absorption are.  
 
As an aid to diagnosis of deficiency, measurement of the vitamin in tissues 
such as plasma and liver has traditionally been adopted, initially using 
microbiological assays. These assays do not differentiate well and uniformly 
between true vitamin B12 and analogues which are also produced by rumen 
bacteria and absorbed (Stabler, 1999). More recently a competitive binding 
assay has been developed which only binds true vitamin B12 through a specific 
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vitamin B12 binder and should provide a more reliable and repeatable method 
(Stabler, 1999). However obtaining liver tissue samples is invasive and 
expensive to conduct and the extent to which they reflect current Co intake is 
difficult to judge. Obtaining a blood sample is much less invasive, easily 
obtained and analysis of vitamin B12 is less expensive. The reference range for 
diagnosis of deficiency is understandably broad, having been based on data 
derived from a range of methodologies with varying specificity and variation 
between trial weight gain responses to vitamin B12/cobolt supplementation 
(Clark et al., 1989). The interpretation is possibly also very broad due to a lack 
of precise understanding of the animal requirement for vitamin B12, and of 
what a plasma value represents in terms of daily supply of the vitamin. The 
vitamin does not appear to have an active role in the bloodstream hence the 
blood is considered to be a transport pool. Due to the complex nature of 
metabolism of vitamin B12, quantitative aspects of cobalt / vitamin B12 
metabolism are poorly understood. As a consequence, plasma reference ranges 
are broad due to a wide range of plasma values where weight gain response is 
greater than 10 g/d are of low probability. There is a need for better 
quantification of the transformation of cobalt to vitamin B12 within sheep. The 
more specific assays available make this line of research much more feasible. 
Further to this, quantification of flow of vitamin B12 in digesta is now possible, 
and opens up the possibility of measuring the influence of rumen conditions on 
vitamin B12 synthesis, efficiency of absorption and therefore supply to the 
tissues.   
 
Given the abovementioned issues, the goal of the present research was to adapt 
and extend the experimental approach developed by Suttle (1974) originally for 
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copper metabolism, to more accurately measure vitamin B12 production and 
absorption in sheep. Having developed such a model, the aim was to test 
factors other than cobalt, such as diet, for their influence on vitamin B12 
production and/or absorption.  
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 CHAPTER 2: Literature Review 
2.1 History of vitamin B12 
In New Zealand, cobalt (Co) deficiency has also been known by the area in 
which it was first found, such examples as ‘bush sickness’ (Askew & Dixon, 
1936), ‘Mairoa dopiness’ (Wright & Taylor, 1931) and ‘Morton Main disease’ 
(Dixon, 1936). The first official report in New Zealand of the disease occurred 
in Tauranga in 1893 (Andrews, 1971). This wasting disease or ill-thrift of 
deficient animals, see Plate 2.1, has been recognised since 1831 in parts of 
Scotland (Andrews, 1971), but not until the early 1930’s was such wasting 
related to Co per se.  
 
Plate 2.1: Cobalt deficient sheep (left) and cobalt supplemented sheep (right) (Clark & Millar, 
1983).  
 
The understanding of how cobalt supplementation rectified the ill-thrift of 
deficient animals was unclear until 1948 when two independent research 
groups, one in the United States headed by Edward Rickes and Karl Folkers, 
and the other in Great Britain with E. Lester Smith (Andrews, 1971) isolated 
vitamin B12. The researchers subsequently demonstrated that vitamin B12 
contained Co and was the factor explaining remission of all clinical signs. 
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2.2 Structure of vitamin B12  
Vitamin B12 is one of a group of cobalamins and has a general formula of 
C63H88N14O14PCo, molar mass of 1355 and contains 4.4% Co (Underwood & 
Suttle, 1999). Micro-organisms in the rumen produce vitamin B12 also called 
cobalamin (cbl), together with a series of vitamin B12-like but inactive 
analogues. Vitamin B12 has a complex molecular structure, (Figure 2.1) 
consisting of a tetrapyrrol group (corrin ring), ribose-3-phosphate group and 
5,6-dimethyl-benzimidazole group and amino-1-propan-2-ol as Coα-ligand, 
and a ‘X’ (Coβ ligand) group. The α-ligand determines metabolic activity 
between active ‘true’ vitamin B12 and inactive analogues. Analogues have a 
modified α-ligand (termed cobamides) or no ligand at all (termed 
cobinamides). The β ligand determines the specific biological activity and can 
occur as a hydroxyl, methyl, 5-deoxyadenosyl, cyanide or sulphuryl group. The 
two coenzymes of major importance for biological processes in the ruminant 
animal are considered to be methyl-cobalamin (Me-cbl) and 5-deoxy-adenosyl 
cobalamin (Ado-cbl)  (Suttle, 1986). Together, these co-enzymes of vitamin B12 
have been estimated to make up approximately 80% of the true vitamin B12 
production in sheep (Gawthorne, 1970). 
 
Figure 2.1: Structure of cobalamins (vitamin B12). 
 
 
Corrin ring 
Co β - ligand 
Co α - ligand 
5,6-dimethyl-
benzimidazole group  
2-amino-1-
propanol-2 
Ribose-3-phosphate 
group 
Tetrapyrrol group 
(hydroxyl, methyl, 5-deoxy-
adenosyl, cyanide or sulphuryl 
group) x 
Co 
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2.3 Function of vitamin B12 
Inter-conversion between the different forms of vitamin B12 can occur. Methyl-
cobalamin (Me-cbl) and 5-deoxyadenosyl-cobalamin (Ado-cbl) are the 
biologically active forms of vitamin B12. It is believed that conversion to the 
appropriate coenzyme forms occurs after transportation into the cells (Gimsing 
et al., 1982). 
2.3.1   5-deoxyadenosyl-cobalamin (Ado-cbl) 
Short-chain volatile fatty acids (VFA) (acetate, propionate and butyrate) are 
the major end products of fermentation in the rumen. Adenosyl-cobalamin 
(Ado-cbl) is a co-enzyme for methyl-malonyl mutase in the conversion of 
methylmalonyl CoA to succinyl CoA (Figure 2.2). Succinyl CoA in turn, enters 
the tricarboxylic acid (TCA) cycle to yield glucose and energy (ATP) via full 
oxidation. In ruminants this process is particularly important as it is the main 
pathway for utilization of propionate in the provision of their glucose 
requirements. Metabolism of propionate in the liver it is considered to provide 
50-80% of glucose needs in roughage-fed animals (Brockman, 1993).  
 
 
Propionic acid (carbohydrates) 
Propionyl-CoA synthase   ↓ 
Propionyl-CoA 
Propionyl-CoA carboxylase   ↓ 
(D)-Methylmalonyl-CoA 
Methylmalonyl-CoA racemase           ↓     (L)-Methylmaonyl-CoA hydrolase 
(L)-Methylmalonyl-CoA          → Methylmalonic acid 
Methylmalonyl-CoA mutase  ↓ 
(Ado-cbl) 
Succinyl-CoA 
Succinic thiokinase   ↓ 
Succinic acid 
 
Figure 2.2: Role of 5-deoxyadenosyl cobalamin (Ado-cbl) in propionic acid metabolism in the 
liver.  
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A consequence of vitamin B12 deficiency is considered to be reduction in energy 
and glucose from glycolysis, with increase in energy from gluconeogenesis or 
oxidation of lipids. The conversion of methyl malonyl CoA to succinate slows, 
and methylmalonic acid (MMA) is hydrolysed from methylmalonyl CoA. 
Methylmalonic acid accumulates in tissues and the bloodstream and is 
excreted in the urine. Periods of low feed intake (as seen in vitamin B12 
deficiency) also stimulate the mobilisation and oxidation of fatty acids of lipids 
(β-oxidation) in the liver to supplement the short fall in energy from glycolysis 
(Figure 2.3). However under vitamin B12 deficiency, the reduction in the 
conversion of methylmalonyl-CoA to succinyl-CoA prevents glycolysis by 
failing to produce the succinic acid for the TCA cycle to yield ATP. In turn, the 
build up of methyl malonyl-CoA also inhibits β-oxidation. The inhibition of β-
oxidation in the liver is one possible explanation for the accumulation of fatty 
acids in the liver of vitamin B12 deficient sheep, causing ovine-white liver 
disease  (Kennedy et al., 1994). 
 
Figure 2.3: Diagram of β-oxidation in the liver of ruminants caused by reduced propionate 
metabolism from vitamin B12 deficiency (Sykes, A.R. lecture material, Lincoln University 
2000).  
 
 8
Kennedy et al, (1991) suggested that large amounts of propionate in the rumen 
can be absorbed at excessive rates. This would place pressure on the Ado-cbl 
dependent methylmalonyl CoA mutase pathway, as propionate is normally 
metabolised rapidly in the liver to succinate. However in the rumen, bacteria 
utilise Ado-cbl to convert succinate to propionate, the opposite direction to the 
pathway which occurs in the liver. This Ado-cbl-dependent pathway may be 
capable of being by-passed to reduce the bacterial dependence on Ado-cbl. The 
result can be high rumen concentrations of succinate and high rates of 
absorption of succinate. This theory was investigated further by Northern 
Ireland researchers (Kennedy et al., 1991) who hypothesised that increased 
rumen succinate production may ameliorate the effects of vitamin B12 
deficiency by reducing the pressure on the propionate (B12-dependent) 
pathway. Logically, it could be assumed that an increase in rumen succinate 
production as a result of change in rumen fermentation may reduce the 
pressure on the vitamin B12-dependent propionate pathway in the animal since 
succinate is readily absorbed (Kennedy et al., 1991). Succinate can then enter 
the TCA cycle directly, bypassing the requirement for conversion of propionate 
to succinate. Further, this may ameliorate the energy/glucose-deficit effects of 
vitamin B12 deficiency. However, Kennedy et al., (1991) found no difference in 
mean plasma MMA concentration even though rumen succinate production 
was increased using severe and moderate Co deficient diets (Kennedy et al., 
1996) as discussed in more detail in section 2.9.  
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2.3.2   Methyl-cobalamin (Me-cbl) 
Methyl-cobalamin is a co-enzyme for the enzyme methionine synthetase for 
transfer of methyl groups from 5-methyl tetrahydrofolic acid (Me THF) to 
homocysteine to form methionine, an amino acid required for wool and body 
growth.  Methyl-cobalamin is required by a number of methyl transferase 
enzymes, acting as a donor of a methyl group (Underwood & Suttle, 1999) 
(Figure 2.4). Vitamin B12 deficiency leads to an accumulation of homocysteine 
and forminoglutamic acid (FIGLU) due to the failure of conversion of 
homocysteine to methionine and THF to 5-formimino THF respectively. Both 
of these accumulated products have been used for diagnostic purposes and are 
discussed later. 
 
Figure 2.4: Role of methyl-cobalamin in methyl transferase enzymes (Gruner, 2001). 
 
2.4 Absorption 
Limited research data exist on the amount of vitamin B12 that is produced or 
absorbed by ruminants or the mechanisms involved. The majority of research 
has been conducted with humans or rodents. Traditionally, aspects of this 
research have been applied under the assumption that human or rodent data 
will be applicable to sheep.  
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Ruminants utilise Co contained within pasture for the synthesis of vitamin B12 
by ruminal bacteria. This is then bound with vitamin B12 binding proteins, and 
is eventually absorbed from the small intestine. Salivary secretions of non-
ruminants contain significant amounts of haptocorrin (HC), a vitamin B12-
binding protein (also commonly known as R-proteins or R-binder). This 
glycoprotein binds with cbl and inactive analogues (Guèant & Nicolas, 1990). 
The isoproteins found in HC are most stable at pH 2.8 - 4.7 (Guèant & Nicolas, 
1990) which would make them unstable in the rumen, but potentially the main 
vitamin B12-binding protein in the anterior part of the post-ruminal digestive 
tract. HC also occurs in plasma, where it is commonly termed transcobalamin I 
and III (TC I or TC III, respectively) (Hansen, 1990; Seetharam & Alpers, 
1994).  
 
Intrinsic Factor (IF) is another vitamin B12-binding glycoprotein which is 
secreted by gastric parietal cells (Glass, 1974; McKay & McLeay, 1979) and is 
stimulated by the presence of food in the stomach (Jacob et al., 1980). 
However the exact physiological mechanism of regulation of secretion is 
unclear. The binding between IF-cbl and the receptor may be Ca2+ and pH 
dependent (Underwood & Suttle, 1999) and optimal between pH 6.4 and 8.4 
(Jacob et al., 1980) or up to pH 10.0 (Glass, 1974).  
 
Vitamin B12 is considered to be preferentially bound to HC in the acidic pH of 
the stomach, the affinity of which is considered to be 50 times that of the IF - 
cbl complex (Allen et al., 1978). Haptocorrin-cobalamin complex and unbound 
IF may proceed to the small intestine where HC is degraded in the presence of 
pancreatic enzymes at the more neutral pH of the duodenal/jejunal section of 
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the small intestine (Guèant & Gräsbeck, 1990), to yield free cbl (Figure 2.5). 
Unbound IF is considered to have a greater affinity for cbl than degraded HC 
(dHC) in the neutral conditions of the small intestine and binds with cbl on a 
one-to-one basis and is carried to the ileum for absorption. 
 
Figure 2.5: Schematic representation of the binding of vitamin B12 and analogues to intrinsic 
factor (IF) and haptocorrin (HC). Black area denotes the protective protein cover of the 
carbohydrate core in the presence of pancreatic enzymes on IF, explaining stability when 
bound. HC is exposed to degradation even when bound (adapted from Guèant & Nicolas, 1990) 
 
Unbound human IF is considered to be partially degraded by pepsin and by 
chymotrypsin when at high concentrations, but is relatively stable when bound 
to a vitamin B12 molecule (Jacob et al., 1980) (Figure 2.5). This allows the IF-
cbl complex to be presented to the intestinal receptor in the terminal ileum. 
Some of the IF that escapes degradation has the potential to bind with cbl 
produced by bacteria in the lower gut or cbl present in bile, the latter being 
available for re-absorption in the ileum of the ruminant (Guèant & Gräsbeck, 
1990). 
2.5 Transport 
Once the cbl is presented to the bloodstream, a proportion is bound to one of 
two main serum proteins; transcobalamin I (TC 1, also termed TC III) or 
transcobalamin II (TC II). Transcobalamin I and TC III are basically 
considered to be immunologically identical, only varying in carbohydrate 
content, particularly sialic acid (Glass, 1974) and fucose (Jacob et al., 1980). TC 
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III may well be an artefact of the isolation process (Burger et al., 1975a). It is 
therefore grouped with TC I hereafter. TC I is a specific serum HC.  
 
Transcobalamin I may also act protective way for the body in regard to dealing 
with potentially toxic cbl analogues. Seetharam & Aplers (1994) have alluded to 
evidence that cbl analogues may gain entry into the bloodstream via IF 
independent mechanisms. Because of the strong affinity of TC I for vitamin 
B12-like compounds, one hypothesis developed is that it provides a potential 
screening process, particularly against inactive analogues that are potentially 
toxic and compete with true cbl for binding and absorption sites (Kanazawa & 
Herbert, 1983). Preferential uptake of analogues by TC I may allow them to be 
transported to the hepatocytes for excretion (Burger et al., 1975b). In the liver, 
analogues are transported into the bile and excreted via the faeces, preventing 
any potential accumulation in metabolically active sites. A summary of the 
transport and absorption process is presented in Figure 2.6. 
 
Figure 2.6: Schematic representation of vitamin B12 production and binding through the 
gastro-intestinal tract and cellular uptake. (adapted from (Alpers & Russel-Jones, 1999)). 
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2.6 Storage 
While the liver is commonly referred to as the storage pool for vitamin B12, this 
may be a misunderstanding. A definition of a storage pool is ‘the reserve of a 
mineral or vitamin that depletes once the transport pool is depleted’ (Grace, 
1994), as seen in copper homeostasis. However when sheep are depleted of Co 
(hence vitamin B12), liver concentration of vitamin B12 depletes in similar 
fashion to serum (Suttle, 1986). Repletion of deficient animals sees serum 
levels increase within hours (Field et al., 1988) but an 8-day lag has been 
observed before liver concentrations increase (Grace, 1998). Since it is 
considered that the liver is the functional site of vitamin B12, it may be more 
appropriate to term the liver as the functional pool, while the blood is 
considered as the storage pool, except during absorption, when it also acts as 
the transport pool. Such differences can help explain the different affinities and 
actions of transcobalamin I and II (TC I and TC II respectively), as explained 
above, with TC I-cbl complexes operating as a storage pool of true and 
analogue vitamin B12 while TC II-cbl complexes act as a transport pool of true 
vitamin B12. 
 
2.7 Excretion 
Human excretion of cbl via urinary losses is considered to be negligible under 
normal vitamin B12 status (Underwood & Suttle, 1999). In the rat, urinary 
excretion of cbl via the kidney only appears to occur when the total binding 
capacity of the blood is exceeded (Cooksley et al., 1974) and surplus cbl (bound 
and unbound) is filtered through the kidneys and excreted, such as after 
injections of vitamin B12. Urinary losses of vitamin B12 were estimated at only 
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1% of that excreted in the faeces in sheep fed a Co deficient (0.02-0.04μg 
Co/kg) diet (Dawbarn & Hine, 1955).  
 
Excretion of vitamin B12 is initially via the biliary route. It is difficult however, 
to estimate true daily endogenous losses of vitamin B12 via faeces as synthesis 
of the vitamin occurs by bacteria in the lower gut (Kercher & Smith, 1956). 
Smith and Marston (1970) showed 95% of radio-labelled 60Co was excreted in 
the faeces within 14 days after oral dosing and 2.5% appeared in the urine. 
However, no attempt was made to determine if the 60Co was present as the Co 
ion or incorporated into the corrin ring of vitamin B12.  
 
2.8 Requirements 
Very few studies have investigated the amount of cobalt required for synthesis 
of vitamin B12 or the amounts of vitamin B12 absorbed and utilised. The 
traditional factorial approach for determining nutrient requirement is 
generally not applicable, due to the lack of production and absorption data 
resulting from the complexity of Co/vitamin B12 metabolism (Grace, 1994). The 
factorial approach allows the measurement of the amount of mineral fed and 
the amount excreted; the difference being apparent absorption. However with 
vitamin B12, sheep consume Co and produce the vitamin internally. Unlike 
humans, which require a regular supply of vitamin B12, ruminants need a 
regular supply of Co for microbial synthesis of vitamin B12 in the rumen. 
Fermented products such as silages and brewers grains contain trace amounts 
of vitamin B12, but otherwise the ruminant is totally dependent on Co intake for 
its vitamin B12 supply. Supplementation by frequent injection of vitamin B12 is 
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possible and effective. Oral dosing of vitamin B12 tends to be ineffective due to 
degradation of the vitamin by rumen micro-organisms.  
 
Estimated minimum pasture Co concentrations for provision of adequate 
vitamin B12 for sheep, determined in supplementation trials or from 
observations of occurrence of clinical symptoms, have ranged from 0.06 mg 
Co/kg DM (Millar & Albyt, 1984) to 0.11 mg Co/kg DM (Grace, 1994). Trials 
with Romney lambs have shown live weight loss and death on pastures 
containing 0.04 – 0.08 mg Co/kg DM (Grace, 1994). The requirements of 
weaned lambs are considered to be higher than those of adult sheep, possibly 
due to their higher growth rate and/or an undeveloped rumen with inadequate 
capacity for vitamin B12 synthesis. Suckling lambs may have a lower 
requirement for vitamin B12 as they receive a supply of lactate from milk and 
are therefore not as dependent on propionate as a source of energy and glucose 
substrate. Lactate can enter the TCA cycle directly, bypassing the vitamin B12-
dependent propionate pathway. Suckling lambs also receive a supply of 
vitamin B12 from the milk which by-passes the rumen and is available for 
absorption from the small intestine. Grace et al., (1986) concluded that milk 
probably provides the majority of suckling lambs vitamin B12, as hepatic stores 
were low until 3 or 4 weeks of age when lambs began to graze pasture and 
develop their own rumen function and synthesise vitamin B12.  
 
Previous methods used to estimate vitamin B12 production in the rumen have 
been indirect and crude. The historical method used for estimating true 
vitamin B12 activity in the rumen was by specific microbial assays. This method 
is time consuming and does not detect low levels of activity with accuracy. The 
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efficiency of conversion of Co into vitamin B12 in the rumen is thought to be 
dependent on the concentration of Co in rumen fluid, and has been estimated 
to decrease from 13 to 3% with increasing Co intake from 0.07 μg to 1.0 mg 
Co/d (Smith & Marston, 1970). However, these latter estimates were based on 
vitamin B12 production data measured by microbiological assay using the ratio 
of vitamin B12 to lignin. Lignin, an internal marker of forage, in rumen fluid 4 h 
after feeding was multiplied by daily intake of lignin. A number of problems 
are associated with this method of internal marking. Water turnover in the 
rumen, with which vitamin B12 - a water soluble vitamin could be expected to 
travel, could be expected to be greater than that of solids such as lignin, and no 
account is taken of the effect of pattern of feed intake. Therefore, the rates of 
production estimated are considered to be minimum values. Initially it was 
thought the microbe used to determine true vitamin B12 activity (Ochromonas) 
was specific for vitamin B12. However, later discoveries found Ochromonas 
responded to other vitamin B12-like factors so that results from such assays 
probably overestimate true vitamin B12 (Dawbarn & Hine, 1955). There is 
evidence that vitamin B12 production is possibly 50% lower on high concentrate 
starch diets (Sutton & Elliot, 1972; Hedrich et al., 1973). Logically, it can be 
hypothesised that the lower fractional outflow rate, and greater cellulose 
fermentation with roughage diets, allows more time and substrate for 
microbial synthesis to capture limited available Co within the diet.  
 
Efficiency of absorption of vitamin B12 produced in the rumen was calculated to 
be 3 – 5% in adult sheep (Marston, 1970), based on the failure of 100 μg 
vitamin B12/d given per os to be as effective as 3 μg vitamin B12/d injected 
intramuscularly, in terms of ability to maintain blood haemoglobin 
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concentration and body weight. A treatment group on a low Co diet (0.04 mg 
Co/kg DM wheaten hay chaff) was given 100 μg vitamin B12/d per os and began 
to lose weight during the period 16-19 weeks after the beginning of the trial, at 
which time a control group receiving the same low Co diet, was also losing 
weight. Treatment with 100 μg vitamin B12/d per os or less did not significantly 
influence weight change or blood haemoglobin concentration until the first 
death of a control animal in week 35. By this time it was obvious to the authors 
that 100 μg vitamin B12/d per os retarded weight loss but not significantly 
enough to prevent loss from the tissues. No account was taken of the possible 
degradation or modification of vitamin B12 administered per os, and the 
question must be raised as to how much vitamin B12 reached the small 
intestine? Vitamin B12 administered orally is degraded rapidly by rumen 
microbes. Smith & Marston (1970) noticed rapid decline in the true vitamin B12 
activity in rumen fluid and an increase in vitamin B12–like compound activity 
during the first 10 h after oral treatment of deficiency with 500 μg 
cyanocobalamin/d. The decrease in true vitamin B12 reflected rapid 
degradation of orally administered cyanocobalamin into vitamin B12 analogues. 
It is possible that small responses to orally administered vitamin B12 may be 
due to degradation of cyano cobalamin to an extent that makes the Co ion 
available for true vitamin B12 synthesis by rumen micro-organisms.  
 
Minimum daily requirements of vitamin B12 for normal growth were estimated 
in wethers fed on Co deficient diets (0.04 mg Co/kg DM wheaten hay chaff) 
and injected parenterally with 3.12, 6.25, 12.5 or 25 μg cyano cobalamin daily. 
Long-term (60 weeks) daily DM intakes were recorded. Maximum intakes were 
obtained when animals were injected with 6.25 μg/d or greater rates of cyano 
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cobalamin. Appetites of all sheep in the 6.25 μg cyano cobalamin/d group fell 
within 6 weeks of cessation of injections. It was also suggested that 6.25 μg 
cyano cobalamin/d was the minimum supplement required to maintain 
normal metabolism of sheep on Co deficient diets and yet it provided little or 
no excess for storage in the liver over animals that received 3.12 μg cyano 
cobalamin/d. Concentrations of the vitamin in the liver were 0.123 and  
0.052 μg vitamin B12/g liver respectively, measured 50 weeks after treatments 
started. In sheep which received 3.12 μg cyano cobalamin/d the onset of 
clinical symptoms of deficiency were delayed until week 30 when some animals 
began to lose appetite. Sheep receiving supplements above 6.25 (namely 12.5 
and 25 μg cyano cobalamin/d) had significantly higher liver vitamin B12 levels 
(approximately 0.4 and 1 μg vitamin B12/g liver respectively), suggesting the 
vitamin was in excess of requirements. However, possible losses of the vitamin 
via urine following intramuscular injections were not considered and 
requirement could therefore have been overestimated. 
 
When sheep were confined to a standard Co-deficient diet estimated rate of 
absorption of vitamin B12/d from the intestinal tract was 5 µg/d. This estimate 
was based on an extrapolation of the 34 μg vitamin B12/d needed to be injected 
intramuscularly to achieve an apparent maximum liver concentration of 1.4 μg 
vitamin B12/g liver after receiving 1 mg (or 10 mg) Co/d in the diet (Marston, 
1970) and an estimate of ruminal production of 700 μg vitamin B12/d (Smith & 
Marston, 1970). The 34 μg vitamin B12/d estimated to be stored in the liver 
following production of 700 μg vitamin B12/d in the rumen equated to an 
absorption efficiency of 5%. However, no effort has been made to separate rate 
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of absorption and utilisation. It was concluded by Marston (1970), that daily 
maintenance requirement for vitamin B12 was about 11 μg/d, and represented 
the sum of the amount needed to be injected to maintain constant serum 
vitamin B12 concentration (6 µg/d) in addition to 5 µg estimated to be absorbed 
from ruminal synthesis, the latter based on data from previous studies by 
Smith & Marston (1970) in sheep on similar diets. The 11 μg vitamin B12/d 
provided ‘normal’ metabolism, without increasing liver concentrations. There 
has been no other evidence on requirement but these values have been 
generally accepted since these earlier studies.  
 
Difficulty in estimating sheep’s requirement for vitamin B12 has been 
associated with the rapid clearance from the bloodstream. The conversion of 
the vitamin to its active forms could be the rate limiting factor (Judson et al., 
1988; Judson et al., 2002). The use of soluble vitamin B12 injections to alleviate 
Co/vitamin B12 deficiency is limited by the length of time plasma levels are 
raised. Under New Zealand conditions, Grace et al., (1998) found 2 mg 
injection was effective in increasing lamb serum vitamin B12 levels for only 24 
days when grazing pasture with 0.08 mg Co/kg DM. In Australia, Judson & 
Babidge, (2002) found 2 mg vitamin B12 prevented metabolic dysfunction for 
less than 51 days. Long-acting vitamin B12 injections have also recently been 
developed. In New Zealand, microencapsulated vitamin B12 copolymer micro-
spheres suspended in peanut oil have prolonged the release of vitamin B12. 
Lambs have been shown to maintain serum vitamin B12 levels significantly 
higher than controls for 210 days when injected with 6mg copolymer vitamin 
B12 (Grace & Lewis, 1999). In Australia, using 2 mg vitamin B12 as cyano-
cobalamin tannin complex suspended in a sesame-oil aluminium monostearate 
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gel elevated plasma vitamin B12 for more than 10 weeks (Judson et al., 2000). 
Clearly, the rapid clearance from the bloodstream shows a need for more direct 
and accurate methods of measuring vitamin B12 production and absorption 
from ruminants. Developments in the measurement of vitamin B12 are now 
possible without the inherent analytical errors associated with microbial assays 
used in the 1970's. The model developed within the present study attempts to 
address these issues.  
 
2.9 Volatile fatty acid production 
Volatile fatty acids (VFA) are the main end product of rumen fermentation 
after the conversion of carbohydrates to pyruvate, and then pyruvate into VFA, 
as linked in Figures 2.7 and 2.8. The type of VFA which dominates in the 
rumen fermentation is dependent on diet (McDonald et al., 1995). Succinate is 
normally metabolised rapidly by other rumen bacteria, the majority of which 
are vitamin B12-dependent (Kennedy et al., 1991), to produce propionate. 
Figure 2.8 shows the production of propionate via two pathways; the lactate 
pathway which dominates from a concentrate-rich diet and the succinate 
pathway which dominates from a roughage-rich diet. A lack of vitamin B12 in 
the rumen prevents the conversion of succinate to propionate and allows 
succinate to accumulate in the rumen fluid. This proposed pathway is the exact 
opposite to the pathway which occurs in the liver. 
 21
 Figure 2.7: Conversion of carbohydrates to pyruvate in the rumen (McDonald et al., 1995) 
 
 
Figure 2.8: Conversion of pyruvate to VFA in the rumen (McDonald et al., 1995) 
 
Under severely Co deficiency conditions (<0.004 mg Co/kg) Kennedy et al. 
(1991 & 1996) were able to demonstrate an increased concentration of 
succinate in the rumen. Investigations were conducted to ascertain whether 
absorption of this succinate can reduce or ameliorate the effects of vitamin B12 
deficiency by offsetting the anticipated reduced succinate synthesis in the liver. 
Three diets containing 0.004, 0.04 and 1 mg Co/kg DM were fed to sheep for 
23 weeks. Ruminal succinate concentration increased 100 fold within 2 days in 
animals on the 0.004 mg Co/kg DM diet and was matched by an equimolar 
decrease in propionate concentration. Sheep on 0.04 mg Co/kg DM (or 
greater) showed no changes in propionate and succinate concentrations. The 
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hypothesis was that sheep on the more severe Co deficient diet promoted 
production of succinate which could be absorbed, thus offsetting the 
requirement for methylmalonyl CoA mutase to convert propionate to 
succinate. However this hypothesis was discarded as the mean plasma MMA 
concentrations of animals on the moderate and severely deficient diets were 
not significantly different, suggesting no reduction in load on the endogenous 
propionate to succinate pathway, even though the diets did promote variation 
in succinate production in the rumen (Kennedy et al., 1996). In practical 
situations, a diet so low in Co is rarely seen.  
 
In this context however, evidence is beginning to accumulate to suggest that 
fermentation type may affect vitamin B12 production, its absorption or its 
utilisation. These include observations of reduced growth of lambs on diets 
providing accepted ‘adequate’ amounts (0.32 - 1.7 mg) of Co per day (Ulvund, 
1990d); development of ovine white-liver disease (OWLD) in lambs grazing 
both ‘deficient’ as well as ‘sufficient’ pastures (Ulvund, 1990c; Ulvund, 1990b). 
In addition, seasonal variation in plasma levels of vitamin B12 in Co 
supplemented and non-supplemented groups of lambs were observed to follow 
the same pattern but at different plasma concentrations (Gruner et al., 2004a). 
In other words, rate of production of the vitamin appeared to vary with factors 
other than rumen Co concentration, rather than showing evidence for a 
constant production of vitamin B12 in supplemented animals, see Figure 2.9 
(Gruner et al., 2004a). If vitamin B12 production was consistent from a 
consistent release of Co, it would be expected that plasma vitamin B12 in Co 
supplemented animals would reach a plateau at which Co supply would 
determine production and/or absorption and therefore serum concentration.  
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Figure 2.9: Changes in serum vitamin B12 (pmol/l) of lambs treated on Day 0 with two cobalt 
bullets (■) or untreated (◊). (Gruner et al., 2004a). 
 
Ulvund & Pestalozzi (1990a) has suggested water-soluble carbohydrates 
(WSC), particularly fructan in pasture grass, as a possible predisposing factor 
to development of OWLD. Perennial ryegrass is rich in WSC, and in particular 
fructan, which accumulates in the early leafy stage of plant growth. Sub-clinical 
vitamin B12 deficiency has been observed in lambs grazing perennial ryegrass 
with high WSC concentrations, but not on ‘healthy’ pastures which did not 
contain perennial ryegrass and had lower WSC contents. The coincidence of 
this observation and the period of lush grass growth supports a hypothesis that 
a high intake of WSC could be a predisposing factor in OWLD (Ulvund & 
Pestalozzi, 1990b) and is investigated within the present study.  
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2.10 Summary 
The traditional factorial approach to estimation of mineral requirement has 
not been possible due the complex nature of vitamin B12 metabolism. Currently 
there is limited information on the amount of vitamin B12 absorbed from the 
gastro-intestinal tract of ruminants due to the historical difficulties of 
measuring true vitamin B12. Generally accepted rates of absorption are derived 
from trials performed in the 1970’s with crude and indirect experimental 
estimates. Information gained from obtaining more accurate information on 
amounts of vitamin B12 absorption and metabolism may allow a better ability 
to interpret plasma vitamin B12 reference ranges. To improve our ability to 
correct vitamin B12 deficiency, an estimate of how much vitamin B12 needed to 
maintain safe serum vitamin B12 concentration is needed.  
 
A similar situation was the case in respect to requirement for copper (Cu), but 
in that case due to analytical errors inherent in measuring low coefficients of 
absorption in conventional balance studies. This was resolved by studying the 
repletion rate of Cu in the plasma of previously depleted animals in response to 
change in dietary Cu intake relative to the amount of Cu needed to be infused 
directly into the bloodstream to achieve the same change in plasma Cu 
concentration (Suttle, 1974). Groups of ewes previously depleted in serum Cu 
were repleted with a diet supplemented with additional Cu providing 2.7 up to 
8.7 mg total Cu/kg for 33 d. In a second trial ewes were depleted in serum Cu 
and repleted via intravenous infusion of Cu to by-pass the absorption from the 
gastrointestinal tract. In other words, the animals were calibrated in terms of 
rate of Cu absorption required to promote change in plasma Cu concentration. 
Calibrated responses were related to responses when additional Cu was 
supplied via the diet to estimated true availability of Cu.  
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 In addition, further investigation is needed examining the effect of rumen 
conditions on synthesis of vitamin B12 and on how non-Co dietary components 
could affect vitamin B12 production and requirement. An extra step (i.e., 
production efficiency of true vitamin B12 in the rumen) is needed to measure 
the rate of production and then absorption. With a model developed to 
measure true vitamin B12 flows within the sheep, animals could be 
supplemented with varying amounts of Co to investigate how production and 
absorption efficiencies change with change in dietary Co intake and other 
possible dietary components. Measurements of the amount of the vitamin 
flowing from the rumen are necessary in order to measure net rate of 
production and a measurement of rate of entry into bloodstream to allow 
estimation of rate of absorption. The aim of the present study was to determine 
whether the repletion technique developed by Suttle 30 years ago for Cu 
metabolism, could be adapted and applied to vitamin B12 metabolism. The 
method of development and results are discussed in the following chapters. 
 26
CHAPTER 3: General Materials and Methods 
3.1 Animals 
Initially, 18-month-old ewes with low vitamin B12 status were obtained from a 
cobalt-deficient farm near Montalto, Canterbury, New Zealand. Young animals 
were used in the expectation of a longer service life than would be the case with 
the use of mature ewes and it would allow rapid establishment of the 
programme with ‘already depleted’ animals. All animals were drenched with  
10 ml combination oral drench for sheep (37.5 g/l levamisole and 23.8 g/l 
albendazole, Arrest, Ancare New Zealand Ltd, Auckland, New Zealand), 
brought into indoor pens and offered a basal diet (see section 3.4) prior to the 
start of the experiment to further deplete plasma vitamin B12 levels. They 
readily adapted to indoor feeding and were fitted with rumen and abomasal 
cannulae. However, after cannulation, these animals lost condition and had to 
be euthanased on welfare grounds. Our observations suggested that the stress 
of surgery coupled with their low vitamin B12 status and physical immaturity 
were critical factors in their poor performance. It was decided to replace them 
with mature ewes which may be better able to handle the combined stress of 
deficiency and surgery. This proved to be the case, but in addition, as a 
precaution the Co deficient diet was improved by the addition of a small 
quantity of crushed barley. The experimental programme was, however, set 
back by nine months.  
 
Consequently, 10 two-and-a-half year old half-bred ewes were obtained from 
the same property and treated as described in the previous paragraph. Eight 
cannulated ewes with plasma vitamin B12 concentrations at least below 500 
pmol/l were used in experiments described in Chapters 4, 5 and 6. During the 
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experiment detailed in Chapter 6, one ewe did not adapt to the high sugar diet 
given and was diagnosed with acidosis after rumen pH fell below 4.8 and 
rumen epithelium sloughed off easily as evident from abomasal fluid samples. 
She was removed from the trial on welfare grounds and removed from any 
statistical analysis due to her abnormal metabolism. A replacement ewe, one of 
the 10 surgically prepared sheep, was used for the remainder of the experiment 
but was ultimately removed from statistical analysis due to initial plasma 
vitamin B12 values being much higher than those of the rest of the treatment 
groups.   
3.2 Cannulation 
The cannulation procedures used were an adaptation of a previously published 
method (Hecker, 1974). Two separate surgical procedures were performed to 
insert rumen and abomasal cannulae. Animals were starved for 24 h and 
removed from water for 12 h prior to surgery. Anaesthetic used was an 
intravenous combination of 0.75 mg/kg bodyweight diazepam (5 mg/ml, 
Pamlin, Parnell Lab NZ, Auckland) and 15 mg/kg bodyweight katamine HCl 
(100 mg/ml, Phoenix Ketamine Injection, Phoenix Pharm Distributors Ltd, 
New Zealand).  
3.2.1  Rumen Cannulation  
A vertical incision was made between the last rib and hipbone on the left-hand 
side, about 10 cm from the lumbar vertebrae, slightly longer than the diameter 
of the cannula neck. The wall of the rumen was held up with Allis forceps while 
another slightly smaller incision was made into the rumen. The rumen mucosa 
was sutured to the abdominal wall with polyglycolic acid suture material 
(coated Vicryl 0 (3.5 metric), Johnson and Johnson Medical Pty Ltd), to create 
a fistula. The cannula flange, (see Plate 3.1) was folded into the neck of the 
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cannula and placed in the rumen, where the flange was unfolded. Permanent 
sutures were placed above and below the incision to close the wound 
completely. Two buttons were placed at the end of the permanent sutures to 
distribute the pressure creating tension sutures. The rubber external retaining 
flange was positioned and held in position by needles. The flange was firm but 
not tight against the abdominal wall as swelling due to oedema tightens the 
flange against the skin. The surgical area was cleaned and dusted lightly with 
2% chlortetracycline HCl powder (Aureomycin Antibiotic Powder, Bomac Lab 
Ltd., New Zealand). Antibiotic cover was provided by 600,000 iu procaine 
penicillin, 600,000 iu benzathine penicillin and 1500 mg dihydrostreptomycin 
(Penstrep LA, Bomac Labs Ltd, NZ) given by subcutaneous injection 
immediately after surgery and again 72 h later.  The animals were then placed 
in a warm recovery room with feed and water. Animals were returned to 
housing 24 h after surgery.  Post-operative analgesia was available but was not 
required as feeding and other behavioural patterns resumed within 4 – 6 h 
following surgery. 
 
Plate 3.1: A) Rumen cannula assembled, B) cannula body, C) retaining ring, D) plug, E) 
retaining ring needle, F) retaining flange. 
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3.2.2  Abomasal Cannulation  
Anaesthesia was induced as for rumen cannulation. A vertical incision was 
then made between the last rib and hipbone on the right-hand side of the 
animal, about 15 cm from the lumbar vertebrae. The abdominal muscle wall 
was separated using blunt dissection.  The abomasum was located and held up 
with Allis forceps while a purse string suture of polyglycolic acid suture 
material (coated Vicryl 2-0 with atraumatic needle, Johnson & Johnson 
Medical Pty Ltd), was placed around the area where the cannula was to be 
inserted.  An incision was then made into the abomasal mucosa slightly bigger 
than the neck of the cannula (see Plate 3.2) and a cannula with an internal 
retaining flange inserted. The purse string suture was then tightened and tied 
off. A stab incision between the last two ribs, the approximate size of the 
diameter of the cannula neck was made. The cannula was returned to the 
abdominal cavity and exteriorised out of the incision between the last two ribs. 
This site was used to avoid occurrence of herniation at the fistulation site.  An 
external retaining flange was positioned over the cannula and held in place by 
a rubber retaining ring positioned by elastrator applicators. The original 
incision was closed using polyglycolic acid suture material (Vicryl 0, Johnson & 
Johnson Medical Pty Ltd).  The surgical area was then cleaned and dusted 
lightly with 2% chlortetracycline HCl powder (Aureomycin Antibiotic Powder, 
Bomac Lab Ltd., New Zealand). Antibiotic cover was provided as for rumen 
surgery.  The animals were then placed in a warm recovery room with feed and 
water. Animals were returned to housing 24 h after surgery.  Post-operative 
analgesia was available but was not required as feeding and other behavioural 
patterns resumed within 4 – 6 h following surgery. 
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 Plate 3.2: A) Abomasal cannula assembled, B) cannula body, C.) rubber retaining ring, D.) 
plug, E.) internal retaining flange, F.) external retaining flange. 
3.3 Liver samples  
To reduce the trauma of liver sampling, it was decided to collect liver samples 
by aspiration liver biopsy while the animal was anaesthetised during abomasal 
cannulation. The method used was an adaptation of the method described for 
use in deer by (Familton, 1985) for use in sheep. Biopsy was attempted once 
the abdominal muscle wall was separated and before the abomasum was 
located. The biopsy cannula (length 200 mm, diameter: o.d. 4.05 mm, i.d.  
3.20 mm) was inserted and gently pushed towards to liver on a 30o angle from 
the horizontal plane.  
 
Liver was felt and identified by the high rigidity and sighted if needed. The 
biopsy cannula was carefully driven into the liver 2 – 3 cm by rotation. A 10 ml 
luer syringe was attached to the external end of the cannula and syringe 
plunger withdrawn approximately 5 ml and cannula and syringe withdrawn 
from the animal. Any liver sample was placed on gauze swab to drain blood. 
The sample was then immediately placed in aluminium foil-covered tubes to 
protect from light.  
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While this method has been used successfully in a wide range of animals, it was 
unsuccessful in obtaining liver samples within the time constraints of an 
anaesthetised animal for abomasal cannulation. It proved very difficult to 
aspirate a sample of liver of sufficient size, since the liver of these already 
vitamin B12 deficient animals was very friable. 
 
As a follow up, one of the initial 18-month-old ewes obtained for 
experimentation (see animals) was euthanased with 10 ml sodium 
pentabarbitone (300 mg/ml) (NZ Veterinary Supplies) to allow practice of the 
technique and extraction of liver samples. Again, extraction of a core liver 
sample proved extremely difficult and unsuccessful. Upon removal, 
penetration of the liver was seen to be successful but samples were so friable 
that none stayed whole to allow clear separation of blood and tissue and the 
sample was considered unsatisfactory for liver vitamin B12 analysis. This 
reinforced the decision not to take liver biopsies from abomasally cannulated 
animals due to this problem, and the additional constraint of the reduced area 
for surgical access with the abomasum adhered to the right flank of the sheep. 
It was decided that liver sampling of these valuable vitamin B12 deficient 
animals was too dangerous for routine components of the work, consequently 
the possibility was abandoned. 
3.4 Diets, water and housing 
The diet consisted of low quality meadow hay made from mature pasture and 
crushed barley sourced from a cobalt-deficient farm near Montalto, 
Canterbury, New Zealand. The quality of the hay was enhanced with the 
addition of urea to increase nitrogen content. All animals were offered and ate 
approximately 400 g of hay, 250 g of crushed barley and 9 g of Nitrogen (N) 
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per day as urea. The hay contained 0.04 mg Co/kg DM and an estimated 7.5 
mega-Joules metabolisable energy (MJME)/ kg dry matter (DM). The barley 
contained 0.01 mg Co/kg DM and an estimated 12 MJME/kg DM. The 9 g N/d 
was provided in 50 ml of urea solution containing 0.2 g N/ml and was poured 
over the diet. The urea solution was made up by dissolving 2.2 kg urea 
(Ravensdown Urea 46% N) providing 1 kg N, in 5 l. Ewes were fed at 
approximately 0900 h each day. All water supplied was deionised. Storage 
drums, hosing and troughs were plastic to ensure that additional cobalt was 
not administered. All pens were lined with untreated downgrade plywood and 
had wooden slat flooring. During active infusion periods pens were modified 
using downgrade 3-plywood in order to temporarily halve the original size 
preventing the sheep from being able to turn around and interfere with 
infusion equipment. An example is given in Plate 3.3. There was no access to 
metal railing. 
 
Plate 3.3: Example of wood-lined pens temporarily halved during the active infusion period 
used in Chapter 6. Note the automatic feeders administering barley during the 4 h after feeding 
of hay.  
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3.5 Feed analysis 
3.5.1  Dry matter percentage (DM%)  
DM % was determined after storing a daily representative sample of the feed 
offered in a clean polythene bag. Weekly sub-samples were dried to constant 
weight at 95oC.  
3.5.2  Soluble carbohydrates 
Soluble carbohydrates were extracted in water and determined 
spectrophotometrically, conducted at Lincoln University, Canterbury NZ as 
detailed in Appendix A. The technique was described by Ministry of 
Agriculture, (1987). 
3.5.3  In-vitro digestibility  
The cellulase assay used for prediction of digestibility was described by 
McLeod & Minson, (1978) and described in Appendix A.  
3.5.4  Metabolisable energy (M/D) 
Metabolisable energy was calculated using predicted % in-vitro digestibility on 
organic matter multiplied by 0.16 as described by Barber et al., (1984). 
3.5.5  Detergent fibre analysis 
Neutral Detergent Fibre (NDF) was determined on hay samples while amylase 
Neutral Detergent Fibre (aNDF) was determined on barley samples due to the 
high starch content. Acid Detergent Fibre (ADF) was determined on both hay 
and barley samples. Respective reagents were prepared as described in Van 
Soest (1963) , Van Soest & Wine (1967) with updates described in Van Soest et 
al., (1991). Specific methodology is detailed in Appendix A.   
3.5.6  Crude protein  
The Kjeldahl procedure was followed to obtain nitrogen content. An accurately 
weighed sample (approximately 0.5 g) of the ground feed was placed in 
 34
digestion tubes with 7 g potassium sulphate (K2SO4) and a selenium (Se) 
catalyst in a 1000:1 ratio K2SO4:Se. Concentrated sulphuric acid (H2SO4), 12 ml 
was added and samples digested for 30 min at 420oC. Samples were cooled and 
analysed on a 1035 Analyser, (Tecator, Sweden) which automatically added an 
excess of 40% sodium hydroxide (NaOH), distilled off the ammonia and 
titrated it against 0.2-molar hydrochloric acid (HCl) to give nitrogen content. 
Indicators used were bromocresol green and methyl red. The N content was 
multiplied by 6.25 to give crude protein content. Samples were corrected for 
dry matter.  
3.5.7  Cobalt content 
Hay and barley samples were sent to Hill Laboratories, Hamilton, New Zealand 
for Co analysis during the experiments and treated as described in Appendix A.  
3.6 Tissue & digesta sample preparation and analysis 
3.6.1  Vitamin B12 in abomasal digesta 
Abomasal samples were collected in 45 ml centrifuge tubes and covered with 
aluminium foil until centrifuged at 28 000 g for 30 min at 4oC. The 
supernatant was decanted off into clean 30 ml conical tubes and a 2 ml sub-
sample placed into a labelled 5 ml polyethylene tube. Samples were stored at  
-20oC until required for analysis when the sub-sample was sent to Gribbles 
Alpha Scientific (Hamilton, New Zealand) for vitamin B12 analysis by 
chemiluminescence. See Appendix A for further detail. The resulting 
supernatant was also used for digesta marker analysis.  
 
Repeatability of determination of vitamin B12 in vitamin deficient abomasal 
samples (n=10) gave a mean of 735 pmol/l with a Standard Deviation (SD) of 
30 pmol/l and Coefficient Variation (CV) of 4.12%. Abomasal samples (n=10) 
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from vitamin B12 sufficient sheep gave a mean of 8950 pmol/l, SD of 372 
pmol/l and CV% 4.16%.  Recovery of vitamin B12 in abomasal fluid spiked with 
vitamin B12 (cyano-cobalamin V-2878, Sigma, USA) to increase concentration 
by 2000, 10 000 and 20 000 pmol/l was 95%, the linear relationship of 
observed vitamin B12 in pmol/l = 0.9454 x the concentration of added vitamin 
B12 in pmol/– 255 with correlation coefficient of 0.9997 (pers. Comm. Julie 
Furlong, Lincoln University, New Zealand).  
3.6.2  Vitamin B12 in plasma samples 
Ten 10 ml vacutainer tubes containing sodium heparin (143 IU, Becton 
Dickinson, USA) were collected at the outset from a sheep with low plasma 
vitamin B12 concentration housed in the animal laboratory. A standard plasma 
sample was sent with each batch of samples for use as an internal reference of 
analytical accuracy. Experimental blood samples were also collected in 10 ml 
heparinised vacutainers. Ethylenediaminotetra Acetic acid (EDTA) is 
considered to have significant effect on the analysis of vitamin B12 and 
therefore, was avoided as an anticoagulant (Diagnostic-Products-
Corporation(DPC), 1999). Samples were covered from light during transport 
and spun at 3000 rpm at 4oC for 10 min. Plasma was pipetted off using 
disposable pipettes and stored in clean plastic vials at -20oC until required for 
vitamin B12 analysis. Samples were analysed at Gribbles Alpha Scientific, 
Hamilton, New Zealand by chemiluminescence (Babson, 1991). See Appendix 
A for further detail.  
3.6.3  Digesta marker concentration 
Polyethylene glycol (PEG) was used as the liquid phase digesta marker. 
Animals detailed in Chapter 5 received 2 g PEG/animal/d and those detailed in 
Chapter 6 received 10 g PEG/animal/d as described in the respective Chapters. 
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Approximately, 40 ml of abomasal digesta was collected and covered with 
aluminium foil until centrifuged at 28 000 g for 30 min at 4oC and the 
supernatant was then stored at -20oC until required for analysis of PEG 
concentration. Polyethylene glycol in abomasal supernatant was determined by 
a modification of the method described by Ulyatt, (1964), which was based on 
the turbidimetric method of Hyden, (1956). Details are described in Appendix 
A.  
3.6.4  Fatty acid analysis 
Rumen liquid (30-40 ml) was collected for fatty acid analysis during the trial 
described in chapter 6. Collection was via a 50 ml syringe connected to flexible 
plastic tubing with 2 mm holes drilled in the sampling end. Once collected,  
20 ml rumen liquid was dispensed into 30 ml plastic conical tubes, pH 
measured and then placed on ice. The last 10-20 ml of rumen liquid was placed 
in a second 30 ml conical tube and acidified immediately for ammonia analysis 
with 5 drops of 2M sulphuric acid to bring the pH below 3, and then placed on 
ice. Samples were stored on ice during sampling and subsequently stored at  
–20oC until required. Fatty acid concentration was determined by Gas 
Chromatography. Details are described in Appendix A.   
 
3.7 Animal Ethics 
All experimentation was conducted under Lincoln University Animal Ethics 
Committee guidelines. Those described in Chapter 4 were performed under 
application number 959, protocol number LU 21/02 and those in Chapters 5 
and 6 under application number 76.  
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4 CHAPTER 4: Calibration of Plasma Response to 
Vitamin B12 Entry Rate 
4.1 Introduction 
The conventional balance techniques to determine nutrient requirement are 
not suitable to estimate vitamin B12 requirements (Grace, 1994) because of the 
complexity of its metabolism. Production of the vitamin occurs in the rumen 
and relies on a regular intake of cobalt for its synthesis by rumen bacteria. 
Without information on this rate of synthesis it is impossible to determine the 
coefficient of absorption of the vitamin in the small intestine. Moreover, since 
the biliary route is a route of excretion and the vitamin can be synthesised by 
bacteria in the hindgut, conventional balance approaches are not helpful, quite 
apart from problems of estimation of the vitamin in digesta. 
  
The present chapter describes an experiment designed to evaluate the 
depletion-repletion approach used by Suttle (1974) to estimate rate of copper 
absorption for the determination of vitamin B12 absorption. Vitamin B12-
depleted sheep were used to determine whether a change in plasma vitamin B12 
initially reflects a change in the rate of entry of the vitamin into the 
bloodstream and to quantify the relationship. If successful, this would open up 
the possibility of predicting rates of absorption of the vitamin for use in other 
studies of factors affecting rates of synthesis of the vitamin in the rumen on the 
assumption that infused vitamin B12 behaves biologically similarly to 
endogenous vitamin B12.   
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4.2 Materials and methods 
4.2.1  Experimental design 
Eight rumen and abomasally cannulated vitamin B12-depleted ewes, as 
described in Chapter 3, were offered approximately 400 g of hay and 250 g of 
crushed barley to continue to deplete plasma vitamin B12 levels. The average 
composition of 7 samples of the diet is given in Table 4.1. The ewes were placed 
in a paired 4x4 Latin square design. Each treatment period of the Latin square 
was run for a total of 21 d, which included a 96 h infusion and a 17 d recovery 
period. Intra-jugular vitamin B12 infusions were set at four levels of treatment, 
namely 0 (control), 7.5, 50 and 200 nmols vitamin B12/day. These were based 
on previous experience of vitamin B12 infusions (Ludemann, 2001) in which 
rates ranging from 0 - 2500 nmol vitamin B12/d for 48 h were used and in 
which the highest dose rate increased plasma vitamin B12 concentration to over 
100 000 pmol/l. Based on these data the highest rate of infusion was 
established as likely to produce concentrations in plasma at the upper end of 
the range seen in practice, namely below 5000 pmol/l.  
 
 
Table 4.1: Mean composition of the components of the diet offered to sheep during an 
infusion of vitamin B12 into the jugular vein.  
Feed Cobalt 
Content 
(mg/kg 
DM) 
Dry 
Matter 
% 
% 
Organic 
Matter 
in DM 
% 
Crude 
Protein 
in DM 
Metabolisable 
Energy (MJ 
ME/kg DM) 
% Digestible 
Organic 
Matter in 
Dry Matter 
Meadow Hay 0.061 90.6 92.8 9.9 8.3 51.9 
Crushed Barley 0.01 86.8 97.8 10.4 14.1 88.1 
Urea 0 95   0  
Diet average 0.041 89.1 94.8 10.1 10.6 66.0 
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4.2.2 Preparation of infusates 
The vitamin was provided as Prolaject (Bomac Lab Ltd, NZ, 1000 µg-
hydroxycobalamin vitamin B12/ml) diluted in isotonic sterile saline solution. 
Infusion bags used were Viaflex® 1000 ml 0.9% sodium chloride (Baxter 
HealthCare Pty Ltd, N.S.W, Australia). A concentrated preparation bag  
(4428 nmol hydroxycobalamin /l) was produced by adding 6 ml of Prolaject to 
the bag after an equivalent volume of saline had been removed. The higher 
concentration was used to produce the lower infusion concentrations by 
dilution. Basically 100, 25 and 3.75 ml of solution from the preparation bag 
was injected into new recipient saline infusion bags after the equivalent volume 
of saline had been removed. The dilution of 1:10, 1:40 and 1:267 from the 
preparation bag made up infusion rates of 200, 50 and 7.5 nmol vitamin B12/d, 
respectively. Four bags of each concentration were made (one bag per 2 d for 
each sheep on each infusion rate). Infusion rate was regulated at 0.32 
ml/minute, equivalent to 461 ml/day. Infusion bags were kept in a darkroom 
next door to the experimental sheep, an example of which can be seen in 
Chapter 6 Plate 6.1. All infusion lines were sterilised by flushing with alcohol, 
rinsed with sterile saline solution and the outside of the lines spray-painted 
black to minimise any destabilisation of the vitamin B12 solution by light and 
the lines primed with solution prior to the start of experiments. Vialon™ 
Insyte™ 16 gauge 1.7 x 45 mm IV catheters (Becton Dickinson, USA) were 
stitched into the left jugular vein. Infusion lines were connected once all 
catheters were in place. Bags were weighed prior to and after infusion and 
actual amounts given calculated by difference. All infusion lines were pumped 
by a ChemLab (England) peristaltic pump - model CPP30. 
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4.2.3  Blood sampling   
Blood collection was done via the jugular catheter during infusions, discarding 
the first 5 ml collected and via the jugular vein during the recovery period into 
10 ml vacutainers. Samples were taken directly prior to attachment of infusion 
lines, time 0 h, and 4, 8, 12, 24, 48, 72, 96, 100, 104 and 108 h and at 5, 6, 8, 11, 
14, 18 and 21 d after the start of the infusion and analysed as described in 
Chapter 3.  
4.2.4  Statistical Analysis 
Plasma vitamin B12 concentrations were analysed using repeated measures 
ANOVA to determine significance of differences and any possible interactions. 
Due to the large scale of the responses, raw data were log10 transformed. 
Exponential curves were fitted to the appearance plasma vitamin B12 response 
(up to time 96 h) using Sigmaplot 8 (Version 14, SPSS Inc, 1999). Due to the 
fact that plasma responses did not reach a plateau in all cases, particularly in 
lower treatment groups, the appearance curve was used to obtain maximum 
peak values for plasma vitamin B12 where the curve reached the upper 
asymptote. Genstat 8 (Release 8.2, Lawes Agricultural Trust, Rothamstead 
Experimental Station, 1997) was used for statistical analysis and graphs plotted 
using Sigmaplot 8.  
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4.3 Results 
4.3.1  Feed intake 
Animals generally consumed all the feed offered which produced an intake of 
0.03 mg Co/d and 7 MJME/d. The starting and finishing live-weight of the 
experimental animals averaged 46 ± 1.14 and 44.9 ± 0.66 kg, respectively. 
4.3.2 Plasma vitamin B12 response to intravenous infusion of 
vitamin B12  
The mean plasma vitamin B12 response to infusion is given in Figure 4.1. 
Infusion of saline maintained relatively stable base line plasma vitamin B12 
levels, values fluctuating between 300 - 400 pmol/L. Pre-infusion plasma 
vitamin B12 levels were similar for all groups but rose sharply within 4 h after 
the start of infusion of vitamin B12 and achieved maximum values after 96 h. 
Peak values were proportional to infusion rate and highly significantly different 
between treatments. Plasma levels declined once vitamin B12 infusions stopped 
and had generally returned to pre-treated levels by the end of each 
equilibration period, 17 d later. Due to the very high plasma levels obtained in 
sheep infused with 200 nmol vitamin B12 /d, some carry-over effect was 
observed but this had no detectable effect on response to the following 
treatment. There were highly significant time and treatment effects and time x 
treatment interactions (P<0.001 in all cases). 
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Figure 4.1: Mean response of log10 plasma vitamin B12 to intravenous infusion of vitamin B12 
(hydroxycobalamin) at rates of 0 (●), 7.21 (□), 48.3 (▲) and 193 (◊)  nmol B12 /d while offered a 
diet containing 0.03 mg Co/d. ▬ denotes period of infusion. Log10 SEM = 0.091.  
 
Fitted maximum responses appearing in the plasma up to 96 h are presented 
in Figure 4.2. To compensate for the fact that plateau values may not have been 
reached at the lower rates of infusion of vitamin B12, exponential curves were 
used to determine maximum values using Sigmaplot 8 (version 14 SPSS Inc, 
1999). These appearance asymptote values were subsequently used for 
calculations of vitamin B12 production and presented on Figure 4.2.  
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Figure 4.2: Fitted maximum appearance response of vitamin B12 in the plasma during 96 h 
intravenous infusion of vitamin B12 (hydroxycobalamin) at rates of 0 (●), 7.21 (□), 48.3 (▲) and 
193 (◊) nmol B12 /d while offered a diet containing 0.03 mg Co/d.  
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4.4 Discussion 
Infusions of 200 nmol/d of vitamin B12 resulted in peak plasma appearance 
levels of vitamin B12 of around 10 000 pmol/l. These were well above generally 
observed clinical values which are usually below 5000 pmol/l when measured 
by Gribbles Alpha Scientific (Hamilton, New Zealand) though values of  
>5000 pmol/l have been observed after supplementation of sheep on pasture 
with more than one Co bullet (Gruner et al., 2004b). The infusion rate of 
200 nmol/d was used in the absence of reliable data in the literature to ensure 
data would encompass results obtained from subsequent Co infusions into the 
rumen. It was not known, at the outset, what the response to infusion would be 
and what the uniformity of response between animals would be. The aim, 
however, was to ensure the entire natural response curve was covered so that a 
region of linearity and high sensitivity could be determined.  
 
The major assumption in the use of this approach to estimate rate of 
absorption of vitamin B12 is that the infused vitamin behaves similarly to, and 
is transported by the same route as endogenous vitamin B12 and the vitamin 
entering the circulation through normal channels of absorption. The 
disappearance rate of vitamin B12 from the plasma was influenced by 
treatment, namely the lowest treatment rate (i.e. 7.5 nmol/d) was cleared from 
the plasma the fastest. There was no difference in disappearance rate between 
50 and 200 nmol/d treatment rates. This result is surprising as it might have 
been expected that all plasma vitamin B12 would be cleared at the same rate, or 
at least the highest treatment level would be cleared the fastest. One could have 
anticipated greater saturation of transport proteins or even the possibility of 
unbound vitamin in the circulation. There is insufficient quantitative data on 
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the metabolism of transport proteins in sheep to assess whether they are 
present in excess normally and/or how quickly proteins are synthesised in 
response to vitamin B12 loading of the plasma.  
 
There is one very important contrast of the current technique to that of the Cu 
depletion/repletion technique of which it is based on. The current model only 
infused vitamin B12 for 4 days which was arguably only marginally long enough 
to obtain steady state plasma concentration. Suttle (1974) infused Cu for 17 
days and the rate of plasma increase reflected synthesis of the transport 
protein caeruloplasmin, as is the case with oral Cu repletion. In future studies, 
vitamin B12 infusions could be restricted to rates at and below 30-nmol vitamin 
B12/d and continued for 14 – 21 days to provide stable plasma concentrations 
reflected by synthesis of transport proteins.  
 
However, the fact that the plasma response to increasing infusion rates of 
vitamin B12 even at 200 nmol/l was tending to exponential (Figure 4.3) may 
suggest that transport proteins had not been saturated or that unbound 
vitamin B12 is not instantaneously excreted. Were that the case, one might have 
anticipated a plateau of plasma concentration if unbound vitamin is more 
susceptible to excretion probably via the kidney. Excretion via the kidney only 
appears to happen when total binding capacity of the plasma is exceeded 
(Cooksley et al., 1974). However, while the assumption of uniform behaviour 
has been made, given the distribution of data points, a linear or sigmoid 
relationship in Figure 4.3 can not be discarded due to the large gap in infusion 
rates, particularly between 50 and 200 nmol/d. A design which used lower 
rates of infusion would have been more informative.  
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Figure 4.3: Mean maximum plasma vitamin B12 response to intra-jugular infusions of 
vitamin B12 (as hydroxycobalamin) at rates of 0 (●), 7.21 (□), 48.3 (▲) and 193 (◊) nmol B12 /d 
while offered a diet containing 0.03 mg Co/d. 
 
The magnitude of response of plasma vitamin B12 concentration from the 
specific vitamin B12 infusions highlights important response issues that need to 
be explained. The plasma vitamin B12 response divided by the rate of infusion 
reveals increases of 44.4, 21.3 and 54.2 pmol plasma B12/nmol B12 infused for 
infusion rates of 7.5, 50 and 200 nmol B12/d respectively. The plasma response 
at the 50 nmol/d rate of infusion was approximately half that at 7.5 and 200 
nmol/d. This raises the possibility that the infused amount was actually closer 
to 25 nmol/d than 50 nmol/d. However after careful review of dilutions and 
procedures this was shown not to be the case. Had the infusion concentration 
been 25 nmol/d, the plasma response to infused vitamin B12 would have been 
linear over the range of infusates used instead of the curvilinear response 
shown in Figure 4.3. The length of time allowed for plasma response to reach 
plateau was arguably too short, particularly at the lower infusion rates and 
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could, theoretically, have been responsible. From responses presented in 
Figure 4.2, it could be argued plasma concentrations were still responding to 
infusion when it was stopped and hence the plateau fitted was too low. It is 
difficult to explain the responses presented if they are a true reflection of what 
occurs when vitamin B12 is naturally absorbed. It is possible that the response 
up to 7.5 nmol/d reflects the uptake of the infused vitamin B12 on transport 
proteins. At the rate of infusion of 50 nmol/d, it is possible that the transport 
proteins could have become saturated and that the rate of excretion of 
unbound vitamin determines the plasma response up to the rate which equates 
with maximum rate of excretion, degradation or transfer to the tissues. 
However, if there is a maximum rate of removal from plasma, it would be 
expected that plasma response at 200 nmol/d would not plateau as in Figures 
4.1 and 4.2. Clearly to fully understand the plasma response to infused vitamin 
B12, the dynamic of transport proteins need to be measured but is beyond the 
scope of this experiment.  
 
The disappearance curves of vitamin B12 from plasma following intravenous 
infusion of vitamin B12 (Figure 4.1) appeared to have two components with 
different half-lives. The initial clearance was very rapid, within hours of the 
cessation of infusion. The second and slower component cleared the 
bloodstream over a number of days. The rapid initial clearance may represent 
the early release of vitamin B12 bound to transcobalamin (TC) II and the slower 
second component may represent release from TC I. The TC II-cbl complex is 
believed to have a half-life between 5 (Chanarin et al., 1978) and 90 min 
(Schneider et al., 1976) in rabbits and humans (Hom, 1967). Rapid clearance of 
TC II-cbl from the plasma probably occurs via the liver, the functional site of 
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vitamin B12. Free cbl released from the liver is considered to be able to re-enter 
the bloodstream bound to TC II for transport to other tissues or bound to TC I 
which has a longer ½ life of approximately 10 d in non-human cells 
(Seetharam & Alpers, 1994) and 9-10 d in humans (Hom, 1967) and appears to 
act as a plasma ‘buffering’ pool. A proposed relationship between TC I and TC 
II is presented in Figure 4.4. After initial rapid absorption by TC II, there is an 
equilibrium with TC I. Such a dynamic between TC I and II could help explain 
the rapid clearance of B12 from plasma after infusion of B12 (within hours) and 
then a lag (over days) until plasma B12 level return to normal as seen in Figure 
4.1. When measuring plasma vitamin B12, no account is taken as to which 
binding protein the vitamin is bound to due to the protein denaturing boiling 
step involved in the methodology. 
Aboma
Liver
Cbl from 
                  
Figure 4.4: Simplified schematic diagram of a proposed relationship between transport 
proteins transcobalamin I and II.  
 
Estimation of extra-cellular fluid (ECF) volume of 10.5 l has been made on the 
assumption that it comprises 245 ml/kg live weight (Coghlan et al., 1977) for 
ewes in low body condition and of the live-weight (43 kg) of the present sheep. 
The total vitamin B12 retained in the ECF can be calculated using peak plasma 
vitamin B12 concentrations (Figure 4.2) less the baseline values at the 0 nmol/d 
infusion rate (naturally occurring vitamin B12 in the bloodstream from native 
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Co present in the diet). When presented as a percentage of the total amount of 
vitamin B12 infused over 4 days at the time of plateau ECF response, ECF 
vitamin B12 represented 12.2%, 6.8% and 12.8% of infused vitamin B12 at the 
infusion rates of 7.5, 50 and 200 nmol/d, respectively. With such a low 
proportion of infused vitamin appearing in the ECF, clearly a large proportion 
is involved in the dynamic between excretion and possible uptake into the 
tissues. For liver uptake to have accounted for the remaining infused vitamin 
B12, based on liver mass of 15 g/kg live weight (Sykes et al., 1980), treated ewes 
would have needed to retain 9.77, 33.8 and 260 nmol vitamin B12/kg fresh 
weight of liver each day. Considering that the normal concentration of vitamin 
B12 in liver in sheep is above 220 nmol/kg liver fresh weight (Grace, 1994), it 
seems unlikely that accumulation of an additional 260 nmol vitamin B12/kg 
liver fresh weight per day would have occurred. Clearly, at this point, liver 
biopsy samples would have been helpful, but due to the problems and potential 
dangers detailed in Chapter 3, changes in vitamin B12 concentrations in liver 
are not available. After initial problems with the original trial animals, these 
sheep were considered too valuable to risk the death of them during a difficult 
liver biopsy. The livers were abnormally friable presumably due to prolonged 
exposure to vitamin B12 deficiency from their property of origin. Urinary 
vitamin B12 may also have helped explain the rapid clearance of vitamin B12 
from the ECF but was not measured. The need to house the animals in sizable 
wood-lined pens in a woolshed prevented the collection of urine at the time of 
planning the experiment. Smith & Marston (1970) showed only 2.5% of an oral 
dose 1 mg Co containing 0.2 mCi 60Co appeared in urine after 14 days but did 
not measure how much Co was actually absorbed.  
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With only 7-13% of infused vitamin present in the ECF, the other 87-93% must 
either have been taken up by cells or excreted from the body. Urinary excretion 
is considered negligible and faecal excretion via the biliary route is very 
difficult to measure and no satisfactory estimate has been made. The problem 
in attempting to estimate excretion from the plasma into faeces is that only a 
small proportion of the vitamin produced in the rumen is absorbed (see 
Chapter 5), so that a large amount appears in the faeces relative to endogenous 
excretion. Also, compounding this is the probable additional production of 
vitamin B12 in the lower gut by bacteria. Therefore, of the vitamin appearing in 
the faeces it would be impossible to differentiate the origin of the vitamin and 
particularly the amount coming from biliary excretion.  
 
If there is a dynamic interplay between plasma and tissues, it is possible that 
apparent movement out of plasma could be lower when tissue levels are 
replete. Gruner et al., (2004b) showed lambs from cobalt bullet supplemented 
ewes which were subsequently supplemented with an intramuscular injection 
of vitamin B12, showed a bigger plasma vitamin B12 response (104 to 1500 
pmol/l) than lambs suckling unsupplemented ewes (95 to 750 pmol/l) even 
though, at the time of injection, plasma vitamin B12 concentrations were 
identical. The dynamic relationship between tissues and plasma could be bi-
directional, for example, movement of vitamin B12 out of plasma into depleted 
tissues could dampen the increases in plasma concentration at high vitamin B12 
intakes, and conversely, at high tissue concentrations movement of the vitamin 
out of tissue into plasma limits reduction in plasma concentration if vitamin 
B12 absorption is reduced. In the absence of tissue concentrations, results from 
the current research suggest that in short-term supplementation, plasma 
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concentration is determined by the rate of entry of the vitamin. This is 
supported by a relatively constant 7-13% of infused vitamin appearing in the 
ECF pool irrespective of infusion rate.  
 
If the data from outside the plasma normal range in Figure 4.3, i.e. the 
response to 200 nmol B12/d are omitted, the infusion rate of vitamin B12 
required to obtain a particular plasma vitamin B12 concentration can be 
calculated and are given in Figure 4.5.  
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Figure 4.5: Working range of maximum individual plasma vitamin B12 response to intra-
jugular infusions of vitamin B12 (as hydroxycobalamin) at rates of 0 (●), 7.21 (□) and 48.3 (▲) 
nmol B12 /d while offered a diet containing 0.03 mg Co/d. 
 
 
 
There was considerable individual variation to response of infused vitamin B12 
the source of which is not known. It may be attributable to variation in tissue 
concentrations as discussed earlier but is difficult to know without this 
 52
information. One possible source of variation in tissue concentration could be a 
previously high rate of infusion in the Latin square, but there was no evidence 
for such carryover effects. Similarly, blocking by animal showed there was no 
significant effect (P=0.100) of animal within each treatment which could 
indicate inherent genetic variation. Suttle, (1974) found repletion of copper 
deficient sheep with intravenous copper for 17-30 d reduced the variation in 
response when comparing individual ‘slow’ and ‘fast’ responding sheep to an 
oral dose of copper. His conclusion was that individual variation was due to 
differences in absorption rather than in post absorptive metabolism of the 
mineral. In future work, it would be advantageous to determine whether tissue 
(predominantly liver), vitamin B12 concentration affect plasma vitamin B12 
concentration and hence response to intravenous infusion of vitamin B12. 
Increasing the duration of infusion period to 8 - 10 d may reduce individual 
variation observed as it would have allowed more time for response to reach a 
maximum asymptote and fitted responses would not have been required.  
 
Despite these reservations, the rate of entry of the vitamin into the 
bloodstream needed to achieve a particular plasma vitamin B12 response when 
absorbed naturally can be predicted from Figures 4.2 and 4.6. These data 
suggests that the plasma reference range used in New Zealand viz, 336 to 500 
pmol vitamin B12/l (Clark et al., 1989) will be maintained by rates of vitamin 
B12 entry into the bloodstream of between 0.15 to 3.3 nmol/d (from Figure 4.6) 
above absorption of vitamin B12 on a diet supplying 0.03 mg Co/d. Once total 
vitamin B12 flow past the abomasum is obtained, absorption coefficient can be 
calculated. The Australian plasma vitamin B12 range is lower than that used in 
New Zealand, namely 200 to 400 pmol/l vitamin B12/l (Judson et al., 1987). 
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The bottom of this range is lower than that of control animals maintained on 
0.03 mg Co/d, being 316 pmol/l. The top of the Australian plasma reference 
range (400 pmol/l) would be maintained by an infusion of 1.1 nmol vitamin 
B12/d above natural absorption of vitamin B12 from a diet containing 0.03 mg 
Co/d.  
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Figure 4.6: Working range of mean fitted plasma vitamin B12 response to intra-jugular 
infusions of vitamin B12 (as hydroxycobalamin) at rates of 0 (●), 7.21 (□) and 48.3 (▲) nmol B12 
/d while offered a diet containing 0.03 mg Co/d. 
 
Historically, the generally accepted requirement for vitamin B12 came from the 
studies of Smith and Marston (1970). These authors estimated vitamin B12 
requirement for ‘normal’ metabolism to be 11 ug/d, made up from 5 ug/d 
absorbed from ruminal synthesis and 6 ug/d that needed to be injected to 
maintain constant serum vitamin B12 without increasing liver concentration on 
a diet containing 0.03 mg Co/d. The diets used by Smith and Marston (1970) 
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and the current data both contained 0.03 mg Co/d, therefore the 6 ug/d 
needed to be injected is the equivalent of infusing 4.4 nmol vitamin B12/d. 
Infusing 4.4 nmol/d would maintain a plasma concentration of 542 pmol/l, 
slightly higher than the New Zealand reference range of marginal vitamin B12 
status. Assuming the reference range used in New Zealand maintains normal 
metabolism of vitamin B12 and doesn’t increase liver concentration, it implies 
the net requirement for vitamin B12 is lower than previous estimates of 11 ug/d 
(Smith & Marston, 1970).  
 
The results from this chapter have calibrated the plasma vitamin B12 response 
to known amounts of vitamin B12 infused and found a response seen in 
practice. While individual variation is evident, this information will allow a 
unit change in plasma vitamin B12 concentration to be used to estimate changes 
in rates of absorption of the vitamin as a result of dietary change. Future 
modifications to the infusion approach for quantifying vitamin B12 rate of entry 
include; 
? Measurement of liver vitamin B12 concentration before and after 
infusion of vitamin B12. Alternative experimental animals and/or 
surgical equipment could provide a solution.  
? Measurement of urinary vitamin B12 concentration. While urinary 
excretion is considered negligible in Co deficient sheep, confirmation 
of this would have helped in the interpretation of the experiment.  
? Intravenous infusion rates of vitamin B12 could have been held at and 
below 30 nmol/d to obtain plasma responses closer to the normal 
range seen in practice.  
 
 55
? Infusions rates of vitamin B12 could have been continued for 14 – 21 
days. This may allow more time for plasma vitamin B12 to reach a true 
equilibrium with infused vitamin B12.   
? Measurement of plasma transport proteins TC I and TC II to help 
better understand plasma vitamin B12 pool responses to increasing 
supplementation of vitamin B12 or increasing Co intakes.  
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5 CHAPTER 5: Intra-ruminal Cobalt Infusions 
5.1 Introduction 
One problem with the use of plasma concentrations to diagnose vitamin B12 
deficiency is our lack of understanding of the quantitative relationship between 
these and the rate of absorption or transport of the vitamin into the body.  The 
fact that the recommended reference range for interpretation of vitamin B12 
status are so broad, is probably, in part at least, a reflection of this lack of 
knowledge. The previous chapter quantified plasma response in terms of the 
amount of directly infused vitamin B12 required to achieve a specific change in 
plasma concentration. With this information the dietary Co supply required to 
achieve a particular rate of vitamin B12 absorption can be determined.  
 
The work described in the current chapter was an attempt to measure the 
range of dietary Co over which the plasma vitamin B12 response curve in 
previously vitamin B12-depleted sheep is sensitive to change in rate of vitamin 
B12 production in the rumen.  
 
If the flow of vitamin at the abomasum is also measured this would provide 
data on the rate of net production of the vitamin. Also with the plasma 
response data determined in the previous Chapter, estimates of the coefficient 
of absorption of the vitamin can be calculated, on the assumption that any 
vitamin synthesised in the hindgut is not absorbed.   
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5.2 Materials and methods 
5.2.1  Experimental design & sampling procedure 
The eight rumen and abomasally cannulated ewes, described in Chapter 3, 
were used in a paired 4 x 4 Latin square design. All sheep were offered 
approximately 400 g of hay and 250 g of crushed barley as described in 
Chapter 3, and were infused with one of four rates of Co directly into the 
rumen for 4 d (96 h) followed by a 19 d recovery period. There were few data 
available on which to calculate rate of infusion. The rates were therefore below 
the lowest single-shot dose of 1 mg Co used by Suttle et al., (1989), with the 
aim of finding the most responsive part of the response curve of vitamin B12 in 
plasma from Co dosing in the rumen. Greater differentiation between 
treatment groups was expected since single-shot treatments varying from 1 – 
32 mg Co showed the same response in plasma vitamin B12 concentration 
(Suttle et al., 1989). From previous experience from single shot intra-ruminal 
cobalt injections of between 0 - 1.0 mg Co/d (Ludemann et al., 2005) showed 
maximum response of 550 pmol/l 48 h after injection of the highest rate which 
returned to original levels after 8 – 10 d. While these responses were within the 
responsive range to treatment with vitamin B12, the infusion of the Co solution 
during 4 d was anticipated to provide a greater range of response. Infusions 
were therefore set at 0 (control), 0.20, 0.60 and 1.0 mg Co/d during 4 d.  
 
Digesta flow at the abomasum was measured with a liquid phase marker 
infused via a separate infusion line commencing 5 d prior to the start of Co 
infusions to allow time to equilibrate. Polyethylene glycol (PEG) 4000 was 
used as a liquid phase marker of digesta instead of the more common, 
chromium ethylenediaminotetra acetic acid (Cr-EDTA) which interferes with 
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vitamin B12 analysis by chemiluminescence. Abomasal samples for the 
estimation of digesta flow were taken after feeding and at 6 h intervals on the 
day before and after, as well as on the 4 days of Co infusion. Samples were 
pooled and measured for each day.  
 
Blood samples were taken on days 0, 5 to 12, 14, 16, 19, 23 and 28 d of each 
treatment period. Samples were prepared and analysed for vitamin B12 as 
described in Chapter 3. The sampling timetable is given in Table 5.1. 
 
Table 5.1.: Sampling and infusion timetable.  
 Wed Thu Fri Sat Sun Mon Tue Wed Thu Fri Sat Sun 
Day 0 1 2 3 4 5 6 7 8 9 10 11 
Co Infusion      Start √ √ √ Stop   
Marker infusion Start √ √ √ √ √ √ √ √ Stop   
Abomasal sample     4x 4x 4x 4x 4x 4x   
Blood samples 1x     1x 1x 1x 1x 1x 1x 1x 
             
 Mon Wed Fri Mon Fri Wed 
Day 12 14 16 19 23 28 
Blood samples 1x 1x 1x 1x 1x 1x Next infusion rate 
 
5.2.2  Preparation and delivery of infusates 
A ChemLab (England) peristaltic pump - model CPP30 was used to deliver all 
infusates and was housed in a darkroom next door to the experimental sheep. 
Actual volumes delivered were calculated as the difference between volume 
before and after infusion. An example of infusion set up can be seen in Chapter 
6 Plate 6.1 (page 85). 
 
5.2.2.1 Cobalt solution 
Solutions were prepared by dissolving an accurately measured 0, 0.517, 1.550 
or 2.584 g of hydrated cobalt sulphate (CoSO4.7H2O) in 1000 ml of nanopure 
water. Aliquots of 100 ml were transferred into 25 l containers and infusion 
solutions made up to volume with nanopure water. Final concentrations were 
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calculated as 0, 0.434, 1.302 and 2.169 mg Co/l, respectively. The solutions 
were regulated by 0.76 mm i.d. pump tube (Astoria Pacific International, 
Oregon, USA) delivering 461 ml/d. The solutions were stored in clean plastic 
containers and kept refrigerated. Samples were sent to R J Hill Laboratories 
Ltd, Hamilton, New Zealand for analysis of Co concentration (for methodology 
see Chapter 3).  
5.2.2.2 Digesta flow marker 
Polyethylene glycol solutions were prepared by weighing 217 g PEG 4000 into 
a 50-litre container, which was then made up to volume with nanopure water. 
The PEG infusion contained 4.34 g PEG/L (2 g PEG/animal/d) and was 
regulated by 0.76 mm i.d. pump tube (Astoria Pacific International, Oregon, 
USA) delivering 461 ml/d. Abomasal digesta flow (l/d) was calculated by the 
ratio of amount of marker infused each day against the concentration of 
marker in abomasal fluid measured as described in Chapter 3.  
5.2.3 Statistical Analysis 
Repeated measures ANOVA on plasma and abomasal vitamin B12 
concentrations over time were used to determine significance of differences. 
Exponential curves were fitted to appearance plasma vitamin B12 concentration 
using Sigmaplot 8 (Version 14, SPSS Inc, 1999). Statistical analysis was done 
using Genstat 8 (Release 8.2, Lawes Agricultural Trust, Rothamstead 
Experimental Station, 1997).  
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5.3 Results 
5.3.1  Feed intake & cobalt analysis 
Animals generally consumed all the feed offered which provided 0.03 mg Co 
and 7 MJME/d. The average composition of 7 samples of the diet is given in 
Table 5.2. Actual concentration of Co in the infusates was 0, 0.505, 1.46 and 
2.44 mg Co/L and provided 0, 0.23, 0.64 and 1.08 mg Co/d.  
 
Table 5.2: Mean composition of the components of the diet offered to sheep during infusion 
of Co into the rumen.  
Feed Cobalt 
Content 
(mg/kg 
DM) 
Dry 
Matter 
% 
% 
Organic 
Matter 
in DM 
% 
Crude 
Protein 
in DM 
Metabolisable 
Energy (MJ 
ME/kg DM) 
% Digestible 
Organic 
Matter in 
Dry Matter 
Meadow Hay 0.061 90.6 92.8 9.9 8.3 51.9 
Crushed Barley 0.01 86.8 97.8 10.4 14.1 88.1 
Urea 0 95   0  
Diet average 0.041 89.1 94.8 10.1 10.6 66.0 
 
5.3.2  Plasma vitamin B12 response to intra-ruminal infusion 
of Co 
The changes in mean plasma vitamin B12 concentrations observed during the 
infusion of Co into the rumen are given in Figure 5.1. There was a significance 
time x treatment effect (P<0.001). Plasma vitamin B12 concentrations of 
animals receiving Co infusion increased from 300 to around 750 – 800 pmol/l. 
Control ewes maintained a base-line plasma vitamin B12 level of approximately 
250 pmol/l. 
 
The pooled mean plasma vitamin B12 response of each treatment group over 
the entire treatment period is given sequentially in Figure 5.2. Plasma vitamin 
B12 levels of all treated sheep started at similar levels to those of control ewes 
but rose rapidly within 4 h after the start of infusion. Although treatments had 
a significant carry-over effect on starting plasma values they appeared to have 
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no effect on the magnitude of response from Co infusions. Plasma levels 
declined within 24 h after Co infusion stopped and returned to pre-treatment 
levels by the end of each treatment, 19 d later. No significant difference in peak 
plasma vitamin B12 concentration was detected between 0.2. 0.6 and 1 mg Co/d 
infusion rates, although clearly the trend was for maximum concentration to be 
determined by rate of Co infusion.  
 
Fitted maximum plasma vitamin B12 responses during the infusion periods 
between are presented in Figure 5.3. Asymptote values were predicted from the 
fitted appearance curves and subsequently used for calculations of vitamin B12 
absorption. 
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Figure 5.1: Mean plasma vitamin B12 response to intra-ruminal infusions of cobalt (as cobalt 
sulphate) at rates of 0 (●), 0.23 (□), 0.64 (▲) and 1.08 (◊) mg Co/d while offered a diet 
containing 0.03 mg Co/d. ▬ denotes period of infusion. 
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Figure 5.2: Pooled mean plasma vitamin B12 response of all animals to ruminal cobalt 
infusions at rates of 0 (●), 0.23 (□), 0.64 (▲) and 1.08 (◊) mg Co/d while offered a diet 
containing 0.03 mg Co/d.  ▬ denotes period of infusion. 
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Figure 5.3: Fitted mean maximum vitamin B12 plasma concentration during 96 h intra-
ruminal infusion of Co at rates of 0 (●), 0.23 (□), 0.64 (▲) and 1.08 (◊) mg Co/d while offered 
a diet containing 0.03 mg Co/d. ▬ denotes period of infusion. 
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5.3.3 Digesta Flow 
The amount of PEG infused proved insufficient to provide concentrations at 
the abomasum which allowed accurate analysis. As a consequence, estimated 
digesta flow rates were variable and unrealistically high. Since the animals 
were offered a fixed amount of the same feed each day and generally consumed 
all of it throughout the trial, irrespective of treatment, digesta flow was 
calculated from data from an additional sub-trial. Basically, four of the trial 
animals were housed, fed and watered exactly as in the original trial. The rate 
of PEG infusion was increased to 10 g PEG/animal/d. Abomasal samples were 
taken daily for 8 d and analysed for PEG concentration and rate of flow 
calculated from these individual samples. The data for individual sheep are 
given in Table 5.3. Average daily liquid flow rates were calculated at 14.6 l/d ± 
0.463 (SEM); the uniformity of flow between individuals and days gave 
confidence in applying these flow rates to sheep in the original experiment 
consuming the same amounts of the same diet.  
Table 5.3: Daily digesta flow rates (litres/d) calculated from digesta PEG concentration 
during retrospective sub-trial. 
  Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Day 8 Mean 
Sheep 1 15.0 11.7 14.4 13.7 17.4 12.4 13.2 9.5 13.4 
Sheep 2 14.3 15.7 13.7 12.0 11.9 14.0 15.1 17.7 14.3 
Sheep 3 15.9 18.8 18.2 18.0 16.1 13.7 12.2 11.8 15.6 
Sheep4 15.0 15.6 18.8 13.7 13.4 12.7 16.4 13.9 14.9 
         14.6 
±0.46 
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5.3.4  Concentration of vitamin B12 in abomasal fluid 
Mean concentrations of vitamin B12 in abomasal fluid are given in Figure 5.4. 
Control sheep maintained a base line abomasal fluid concentration of around 
2000 pmol vitamin B12/l.  
 
There was a significant effect of time and treatment (P<0.001 in both cases) on 
abomasal vitamin B12 concentration (pmol/l) which had risen sharply within 
24 h after the start of Co infusion. The highest concentrations (approximately  
10 000 pmol/l) were obtained with infusion of 1.08 mg Co/d.  
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Figure 5.4: Change in mean vitamin B12 concentration in abomasal fluid in response to 96 h 
intra-ruminal cobalt infusions at rates of 0 (●), 0.23 (□), 0.64 (▲) and 1.08 (◊) mg Co/d while 
offered a diet containing 0.03 mg Co/d.  ▬ denotes period of infusion. Curved lines represent 
fitted maximum values. 
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5.4 Discussion 
5.4.1  Diet 
The aim was to use a diet that maintained the animal in a deficient state 
without inducing a severe dysfunction. Due to the low quality of the meadow 
hay given, crushed barley and urea were added to provide fermentable 
metabolisable energy to enhance cellulytic activity and microbial protein 
synthesis from rumen degraded protein supply in order to maintain reasonable 
intakes. Cobalt content was still kept to a minimum to maintain deficiency 
status (0.03 mg Co/d) and was still at levels of deficiency seen in practice 
rather than the extreme deficiencies used by other authors and which can 
impose a dysfunctional state (Kennedy et al., 1991; Kennedy et al., 1996). In 
pastoral situations, diets are very rarely seen with Co concentrations as low as 
used by these latter authors; the present data do represent Co intakes likely to 
be experienced in practice, albeit at the low end of the range.   
5.4.2 Digesta flow 
Polyethylene glycol (PEG) was used as a liquid phase marker due to the 
possibility of interference of chromium EDTA in the analysis of vitamin B12 by 
chemiluminescence (Diagnostic-Products-Corporation(DPC), 1999). Infusion 
rates were kept low to minimize any modification of rumen fermentation. PEG 
can bind with tannins in the feed and remove the protection of protein against 
degradation by rumen microbes. As little as 1.8 g PEG will bind 1 g of tannins 
(Barry & Forss, 1983). However, concentrations of PEG were unexpectedly low 
and difficult to measure reliably so that the resulting liquid flow calculations 
were unexpectedly variable. The rate of infusion subsequently adopted, viz 10 g 
PEG/animal/d, was comparable to rates used by van’t Klooster et al., (1969). 
Moreover, tannins in meadow hay diets like the one used typically contain less 
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than 1% tannin (pers. Comm. Barry, TN) so any modification of the protein 
digestion in the rumen by PEG was probably minimal. Estimated liquid flow 
rates were very consistent both within and between animals, and were similar 
quantitatively to flow rates at the abomasum observed by previous workers in 
sheep consuming similar diets at the present rates of intake. For example,  
van 't Klooster et al., (1969) found Texel sheep had a mean flow rate of 14 - 20 
l/d on intakes of 970 g/d of a hay diet. Phillipson & Ash, (1965) found Clun 
Forest sheep had flow rates of 10 – 12 l/d when offered 700 – 1000 g of a hay 
diet. The calculated average flow rate of 14.6 l/d (±0.463 SEM), which was 
subsequently used for calculations of total vitamin B12 flow through the 
abomasum, therefore would seem to be realistic and reliable.  
  
5.4.3 Concentration of vitamin B12 in plasma after intra-
ruminal cobalt infusions 
The positive relationship between cobalt intake and plasma vitamin B12 
concentrations has been well understood with ruminal synthesis of vitamin B12 
increasing with increased supply of cobalt, but with diminishing efficiency 
(Suttle et al., 1989). The relationship found in the present work are presented 
in Figure 5.5. While plasma vitamin B12 increased with (or in response to) 
increasing cobalt intake, the size of the response similarly reduced with 
increasing Co supply over the range of 0.03 to 1.11 mg Co/d. This curvilinear 
trend is similar to that observed by other authors (Gawthorne, 1970; Marston, 
1970; Hedrich et al., 1973; Suttle, 1986).  
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Figure 5.5: Relationship between daily cobalt supply to the rumen and peak plasma vitamin 
B12 concentration.  
 
5.4.4 Plasma vitamin B12 disappearance rate 
The technique of estimating the amount of vitamin B12 absorbed using 
infusions of the vitamin directly into the bloodstream against the plasma 
response from intra-ruminal Co infusions is based on the assumption that 
infused vitamin B12 behaves identically, biologically, to vitamin B12 absorbed 
from the alimentary tract. The magnitude of plasma concentration of vitamin 
B12 after 200 nmol/d vitamin B12 was infused was 14 times higher than the 
greatest response seen after Co was infused into the rumen (11 600 pmol/l vs 
805 pmol/l, respectively), therefore a difference between trials might have 
been expected. However, after removing the response to infusion of 200 nmol 
B12/d (Chapter 4), the difference between trial rate coefficients was still 
significant (P<0.001). The most plausible explanation for the difference 
between trials may simply have been caused by a delay of the reduction of 
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entry of the vitamin into the circulation after withdrawal of Co 
supplementation into the rumen. When Co infusions were stopped, plasma 
vitamin B12 concentrations were still elevated 24 h later as seen in Figure 5.1. 
This reflects a time lag between production and appearance in the plasma. 
However, when vitamin B12 infusions were stopped, there was no time lag and 
plasma concentration began to decrease immediately. To validate the 
assumption that infused vitamin B12 behaves biologically similar to 
endogenous vitamin B12, transport proteins need to be measured.  
 
The broad likeness in behaviour between modes of entry of the vitamin into the 
bloodstream is perhaps an indication that infused and absorbed vitamin 
behave similarly. For vitamin B12 infusions, disappearance rate coefficients 
were 0.053, 0.020 and 0.018 as infusion increased from 7.5, 50 and 200 
nmol/d, respectively. For Co infusions, disappearance rate coefficients were 
0.0140, 0.0097 and 0.0076 as infusion increased from 0.2, 0.6 and 1 mg Co/d 
respectively. For both methods of entry into the plasma, vitamin B12 was 
cleared the fastest at the lowest treatment level. This may imply equilibrium 
between plasma and tissue which maintains plasma levels with fall in rate of 
entry to the circulation, with plasma levels being maintained longer if the 
tissues are more replete after higher rates of infusion. Clearly data on changes 
in tissue concentrations will be required to test this hypothesis.   
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5.4.5 Flow of vitamin B12 in abomasal fluid and its absorption 
A positive curvilinear trend was noticed between cobalt intake and vitamin B12 
concentration in abomasal fluid (Figure 5.6). This production relationship saw 
a large response to the first increment of Co and reduced responses to further 
increments of Co. This could be explained by a diminishing efficiency of 
production of vitamin B12. This implies that the rate of production of vitamin 
B12 is optimized at relatively low dietary concentrations and that the ability of 
microbes to capture additional cobalt and incorporate it into vitamin B12 is 
diminished with increasing Co intake. Clearly, at the higher rates of infusion 
another factor other than Co was limiting the production of vitamin B12 in the 
rumen. Another very plausible factor could be the amount of metabolisible 
energy available for microbial growth. The total amount of vitamin B12 
available for absorption can be calculated by converting the concentrations of 
vitamin B12 in abomasal fluid into a flow of vitamin B12 per day. From daily 
digesta flow rates of 14.6 l/d multiplied by vitamin B12 concentration in 
abomasal fluid, daily flow of vitamin B12 can be calculated (Figure 5.7). The 
maximum appearance of plasma vitamin B12 per unit of metabolisable energy 
can be calculated from abomasal fluid concentrations in Figure 5.4, an energy 
intake of 7 MJME and digesta flow of 14.6 l/d equates to 4.75, 15.4, 17.4 and 
20.2 nmol B12/MJME at Co intakes of 0.03, 0.26, 0.67 and 1.11 mg Co/d 
respectively.  
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Figure 5.6: Relationship between total ruminal cobalt supply and peak vitamin B12 
concentration in abomasal fluid. 
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Figure 5.7: The relationship between peak plasma vitamin B12 concentration and flow of 
vitamin B12 (nmol/d) in abomasal fluid. 
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It might be anticipated that transport of vitamin B12 across the gastrointestinal 
tract (GIT) will saturate implying a limit to the amount of vitamin B12 that can 
be transported per day. When plasma concentration is plotted against 
abomasal flow (Figure 5.7) this does not seem to have been the case. Across the 
present range of supply to the intestine response of plasma concentration to 
increase in abomasal vitamin B12 flow was linear. Rate of production in the 
rumen and concentration of the vitamin at the abomasum seem to have been 
the limiting factors to plasma concentration at the present rates of production 
since flow rates were the same between animals. 
 
5.4.6  Efficiency of Production of vitamin B12 
When known amounts of Co are administered each day, the theoretical 
maximum vitamin B12 production can be calculated since it is known the cobalt 
ion weighs 4.35% of the total weight of vitamin B12. The abomasal vitamin B12 
concentration multiplied by daily liquid flow rate (see Figure 5.7) gives a total 
flow of vitamin B12 flowing past the abomasum which is potentially available 
for absorption. The total flow can be converted to a total weight of vitamin B12 
allowing comparison of the same units as the theoretical maximum vitamin B12 
production. The production efficiency of vitamin B12 can be calculated from the 
ratio of total weight of vitamin B12 flowing past the abomasum against the 
theoretical maximum production of vitamin B12 as seen in Table 5.4. An 
example calculation is presented in Appendix B.  
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Table 5.4: Estimate of efficiency of vitamin B12 production after ruminal cobalt infusions. 
 
Cobalt intake Theoretical 
maximum B12 
production* 
Maximum 
abomasal conc 
measured. 
Total abomasal 
B12 flow** 
Production 
efficiency 
(mg Co/d) (mg Vitamin 
B12/d) 
(pmol/l) (mg B12/d) (%) 
0.03 0.69 2277 0.045 6.52 
0.26 6.0 7376 0.146 2.43 
0.67 15.4 8682 0.172 1.12 
1.11 25.5 9706 0.192 0.75 
*Assuming 100% incorporation of Co into vitamin B12 and that 100/4.35 mg vitamin B12/mg Co 
**Assuming digesta liquid flow of 14.6 l/d  
 
When production efficiency is represented graphically (Figure 5.8) it shows an 
exponential reduction in capture of Co in vitamin B12 as Co intake increased.  
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Figure 5.8: Production efficiency (%) of vitamin B12 with increasing cobalt intakes 
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These efficiencies are in the same range but tend to be lower than the estimates 
of Smith and Marston (1970) of 13 – 3% on increasing cobalt intakes between 
0.03 and 1 mg Co/d, though they, similarly, found that efficiency decreased 
with increasing Co intake.  However, Smith and Marston’s estimate was 
derived from data based on the concentrations of cobalt and vitamin B12 in the 
rumen before and after withdrawal from oral drenches of 1 mg cobalt per day.  
 
A possible reason for Smith and Marston’s production estimate being higher 
than the current is that their measurement of vitamin B12 was by a microbial 
(Ochromonas) assay which presents difficulties in the detection of low 
concentrations of vitamin B12 with accuracy. It is also possible with such 
analytical methods measurement of vitamin B12 was artificially high due to the 
measurement of vitamin B12–like compounds. Little reliable literature exists on 
the specificity of microbial assays for vitamin B12. Millar & Penrose, (1980) 
found a high correlation (R2=0.92 at significance level 0.1) between serum 
vitamin B12 measured by microbiological and radioassay methods. However the 
radioassay values were higher than microbiological unless a purified intrinsic 
factor was used, when values were lower than microbiological methods. Given 
the variation between assays, it is difficult to conclude which assay best 
measures true vitamin B12 and excludes vitamin B12 -like compounds. Vitamin 
B12 in the current research was measured by chemiluminescence, which 
excludes analogues due to use of purified hog Intrinsic Factor which only binds 
true vitamin B12 (after a boiling step to denature proteins). This could be 
another reason for the current estimate of production efficiency being lower 
than previous reports of production. Nevertheless, the difference between 
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estimates is small and the present reinforces the earlier conclusion that 
efficiency of capture of Co in vitamin B12 by rumen micro-organisms is low.  
 
Another factor which could affect vitamin B12 production in the rumen is the 
amount of fermentable metabalisable energy (FME) available for microbial 
production. The diet used within this research supplied approximately 8.8 MJ 
FME/d based on data for FME from McDonald et al., (1995). The diet used by 
Smith and Marston (1970) would have supplied less FME (estimated 6.5 MJ 
FME/d) due to the higher proportion of hay-chaff. However, this does not 
account for their higher estimate of production.  
 
5.4.7  Absorption of vitamin B12  
In the previous chapter plasma vitamin B12 concentration responses were 
calibrated for rate of entry of the vitamin into the plasma pool (Figure 4.6). It is 
now possible to relate plasma vitamin B12 responses against abomasal flows of 
vitamin B12 to allow an estimate of rate of vitamin B12 absorption (Table 5.5) 
and therefore the absorption coefficient. An example calculation is given in 
Appendix C.  
 
Table 5.5: Estimation of the absorption coefficient from vitamin B12 flow in the abomasum 
and plasma response from ruminal cobalt infusions and the equivalent plasma response from 
an intra-jugular vitamin B12 infusion.  
 
Co 
intake 
(mg 
Co/d) 
Abomasal 
flow of 
vitamin B12 * 
(nmol/d) 
Plasma 
response 
(pmol/l) 
B12 infusion rate to give 
equivalent plasma 
response (nmol/d) 
(Chapter 4, Fig. 4.6) 
Estimated 
absorption 
coefficient 
(%) 
0.03 33.2 248 - - 
0.26 108 640 7.3 6.8 
0.67 127 748 10.9 8.7 
1.11 142 833 14.1 9.9 
*Assuming digesta liquid flow of 14.6 l/d 
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The vitamin B12 responses to infusions of vitamin B12 or Co were the responses 
measured in addition to the endogenous vitamin B12 absorbed from the basal 
diet containing 0.03 mg Co/d. Therefore the estimate described in Table 5.5 is 
based on additional vitamin B12 supplied directly into the blood above vitamin 
B12 absorbed from the basal diet. In an ideal situation, control animals would 
maintain the same plasma concentrations in Chapters 4 and 5. However 
control animals maintained a slightly higher plasma concentration, albeit a 
small difference, in the calibration of Chapter 4. There is a very real possibility 
this is caused by short-term carry-over effects from high treatment rates in 
Chapter 4, artificially inflating animal values when used as a control in 
subsequent treatments, as discussed in the present chapter.  
 
Coefficients of absorption calculated over the range of abomasal vitamin B12 
flows obtained ranged from 6.8 to 9.9% and tended to be greatest at highest 
abomasal flow of the vitamin. This result is a little surprising as it might have 
been expected that as abomasal flow of vitamin B12 increases, absorption 
coefficient might decrease. However, the plasma responses from increasing 
abomasal flow of vitamin B12 are not significantly different. Therefore the 
difference in plasma response over the range of flow of 105 – 141 nmol/d of 
vitamin B12 at the abomasum seems mainly to be due to the change in 
efficiency of capture of Co, namely decreasing from 2.5 to 0.75% Co 
incorporated into vitamin B12 respectively, the effect being minimized by the 
trend for increasing absorption efficiency of the vitamin.  
 
Marston’s (1970) calculation of a coefficient of absorption of 3% was estimated 
by the failure of 100 ug vitamin B12 given per os to be as effective as 3 ug 
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vitamin B12 injected intramuscularly, in terms of change in mean haemoglobin 
concentration and body weight. This suggests oral dosing of vitamin B12 is 
ineffective way of supplementing sheep. It may be inappropriate to compare 
this method of supplementation with other methods, namely oral dosing of Co 
as administration of vitamin B12 per os allows the vitamin to be degraded by 
the rumen microbial population and hence rendered unavailable for 
absorption. Possible responses may be due to release of cobalt ion due to 
degradation, which subsequently makes the ion available for true vitamin B12 
production by the microbes. However, limited data exists on the extent of 
degradation of vitamin B12 in the rumen. Smith & Marston, (1970) 
demonstrated a rapid decrease in supposed ‘true’ vitamin B12 10 h after oral 
dosing with 500 ug cyanocobalamin and an equal increase in vitamin B12–like 
analogues.   
 
The plasma reference range used in New Zealand viz, 336 to 500 pmol/l 
(Underwood & Suttle, 1999) was calculated, in Chapter 4, to equate to a direct 
intravenous rate of infusion of vitamin B12 of between 0.15 to 3.3 nmol/d. 
Based on the present work, Figure 5.7, the plasma concentrations in the 
reference range equate to an abomasal flow of vitamin B12 between 50 to 80 
nmol/d. Converting this flow rate to a concentration of vitamin B12 based on a 
digesta flow of 14.6 l/d gives a concentration of vitamin B12 in abomasal fluid of 
2527 and 4044 pmol/l respectively. At these concentrations, the relationship 
listed in Figure 5.6 equates to a Co intake of 0.041 and 0.057 mg Co/d. The 
suggested plasma reference range appears therefore to be supported by a 
dietary intake of 0.041 to 0.057 mg Co/d, lower than the estimated minimum 
dietary requirement of 0.1 mg Co/d (Grace, 1994).  
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While high plasma vitamin B12 responses (>3000 pmol/l) are seen from direct 
supplementation of sheep with vitamin B12, in pastoral situations responses are 
generally more modest below 2000 pmol/l. In the present work, intra-ruminal 
infusions of 1 mg Co/d only increased plasma to a maximum plateau value of 
approximately 800 pmol/l. It has been clearly demonstrated that plasma is 
capable of carrying very high loads of vitamin B12, yet under relatively high Co 
intakes (1 mg Co/d) more modest plasma levels were observed during short-
term trials. Results from the present Chapter showed production efficiency 
decreased from 6.5 to 0.75% as Co intake increased from 0.03 to 1.11 mg Co/d. 
This decrease in production efficiency was offset by an increase in absorption 
efficiency of 6.8 to 9.9% as Co intake increased from 0.26 to 1.11 mg Co/d. 
Modifications to the present trial design would include; 
• Restrict Co infusions to the period of feeding for better simulated 
grazing situation.  
• A longer infusion period of 17 – 30 d as it was proved in Chapter 4 
that 4 days of direct infusion into the bloodstream was marginally 
long enough to reach an appearance asymptote. 
• Use of a diet higher in ME but low in Co to maintain animals 
deficient of vitamin B12 but prevent any potential limitations of 
microbial activity.  
• Measurement of urinary vitamin B12 concentration. While urinary 
excretion is considered negligible in Co deficient sheep, 
confirmation of this would have helped in the interpretation of the 
experiment.  
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6 CHAPTER 6: Effect of Carbohydrate Source on 
Vitamin B12 Production and Absorption 
6.1 Introduction 
While it is well documented that dietary cobalt (Co) concentration is the major 
limiting factor in vitamin B12 deficiency, there is evidence that other factors 
may influence vitamin B12 status of the host. Gruner et al., (2004b) observed 
that Co pellet-supplemented animals, although showing elevated plasma 
vitamin B12 levels, still showed a seasonal pattern of change with time which 
mimicked concentrations in un-supplemented animals with rises and falls in 
plasma levels occurring at the same time. If cobalt were the only limiting factor 
in vitamin B12 production, it could be assumed that in the Co-supplemented 
animals, vitamin B12 production would increase and plateau at a rate consistent 
with the rate of release of cobalt from the pellet, rather than the fluctuations 
seen. Other factors therefore appear to be promoting and/or restricting the 
production or absorption of vitamin B12. It may simply reflect seasonal 
variation in metabolisable energy intake, but components of the diet could also 
be implicated. 
 
OWLD appears to mainly affect lambs during rapid pasture growth on a diet 
lacking cobalt (Kennedy et al., 1994) and rich in readily digestible 
carbohydrates (Ulvund, 1990a) and was first described in New Zealand by 
Sutherland et al. (1979). Anecdotal evidence has associated the deficiency with 
high quality reseeded pastures. These would have the characteristic of high 
levels of soluble carbohydrate, given the dominance of grass in reseeds, and a 
low content of clover, which is known to maintain a higher Co concentration 
than grasses, reducing potential daily Co intake and increasing soluble 
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carbohydrate intake. Ulvund & Pestalozzi, (1990a) for example, have observed 
variation in plasma vitamin B12 concentrations and susceptibility of sheep to 
ovine white liver disease (OWLD) between seasons on herbage with the same 
Co concentration. These authors speculated that variation in soluble 
carbohydrate levels, especially fructan levels, may be implicated. This seems 
entirely plausible as the rate of vitamin B12 synthesis in the rumen seems likely 
to be a reflection of the growth and activity of rumen micro-organisms. The 
aim of the present trial was to determine whether the source of carbohydrate 
for rumen microbial energy influences rate of vitamin B12 production and 
absorption. 
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6.2 Materials and methods 
6.2.1  Experimental design 
Eight rumen and abomasally cannulated vitamin B12-depleted ewes were used, 
as described in Chapter 3, in a 2 x 4 cross-over design employing two energy 
sources on two groups of 4 sheep. Dietary treatments were intra-ruminal 
infusion of a soluble carbohydrate (sugar)-enriched diet or the continuation of 
the barley (starch)-enriched diet. Animals receiving the sugar-enriched diet 
were introduced to the diet by gradual substitution of barley for sugar during 
the first 7 d of a 28 d period. On day 7, intra-ruminal infusion with 0.3 mg 
Co/d was commenced and continued until day 13. Cobalt infusion rates were 
based on data from Chapter 5 in which 0 – 1.0 mg Co/d was infused intra-
ruminally for 96 h. The most responsive section of the dose-response curve was 
at the rate of infusion of 0.3 mg Co/d, the estimated infusion rate for the 
optimal response of plasma vitamin B12 and therefore subsequently used in the 
current trial. Days 14 – 28 were a recovery period until the next period started. 
Infusions of digesta marker solution was started on day 2 and continued until 
day 13.  
6.2.2  Sampling procedure 
Blood samples were taken on days 0, 7, 10, 13, 14, 18, 23 and 28 of each 
treatment period. Samples were prepared and analysed for vitamin B12 as 
described in Chapter 3. Abomasal samples (approximately 40 ml) were taken 
once each day during days 7, 8 and 13 and 4 times each day (4am, 10am, 4pm 
and 10pm) on days 9, 10 and 11 for estimation of digesta flow. Samples were 
covered with aluminium foil until centrifuged at 28 000 g for 30 min at 4oC 
and the supernatant then stored at -20oC until analysed for vitamin B12 and 
PEG concentrations as described in Chapter 3. 
 81
 Rumen samples were taken for analysis of ammonia and fatty acid (FA) 
concentration at 0, 2, 4, 6, 8, 12 and 24 h after feeding on day 12 as described 
in chapter 3. The detailed sampling procedure is summarised in Table 6.1. 
 
Table 6.1: Feeding regime, infusion times and sampling procedure for sheep during the 
experimental period.  
 Mon Tues Wed Thurs Fri Sat Sun 
Day 0 1 2 3 4 5 6 
Sugar:barley substitution 
for applicable animals 
150 g 150 g 200 g 200 g 250 g 250 g 250 g 
PEG Infusion   Start - - - - 
Blood Sampling 1x       
 Mon Tues Wed Thurs Fri Sat Sun 
Day 7 8 9 10 11 12 13 
Cobalt and Urea and (Sugar 
- if applicable) Infusions  
Start - - - - - Stop 
PEG Infusion - - - - - - Stop 
Rumen Sampling       6x 1x 
Abomasal Sampling 1x 1x 4x 4x 4x  1x 
Blood Sampling 1x   1x   1x 
 Mon Fri Wed Mon 
Day 14 18 23 28 
Blood Sampling 1x 1x 1x 1x 
 
6.2.3  Diets 
6.2.3.1 Starch enriched diet 
The diet consisted of low quality chaffed meadow hay, crushed barley and urea 
solution to balance rumen fermentation as described in Chapter 3. Animals 
were offered and consumed approximately 400 g DM of hay once a day, 250 g 
DM of crushed barley and 9 g DM of urea per day given over a 4 h period after 
the hay was offered to the sheep. During the experimental period, the barley 
was given via belt-driven feeder and the urea solution was supplied via intra-
ruminal infusion line during the 4 h period from feeding of the hay to help 
simulate nutrient supply in normal pastoral grazing situations.  
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6.2.3.2 Sugar enriched diet 
The quality of the diet was modified by the substitution of an infusion of 
soluble carbohydrate directly into the rumen for crushed barley. Animals were 
offered and consumed approximately 400 g DM of hay once a day and 
received, via infusion directly into the rumen, 210 g DM fructose (Raftilose, 
R.M.F Marketing Service, Christchurch, New Zealand; 95% oligofructose): 42 g 
DM sucrose (BDH Laboratory Supplies, Poole, England) per day in an 80:20 
fructose:sucrose mix and a total of 21.5 g DM of urea to balance the two diets 
for N source. The sugar and urea were administered over the 4 h period after 
the hay was offered to the sheep.  
 
Methods of estimating metabolisable energy and percent of soluble 
carbohydrate of each diet are described in Chapter 3. 
 
6.2.4  Preparation and delivery of infusates 
The Co solution was prepared by accurately measuring 0.777 g of hydrated 
cobalt sulphate (CoSO4.7H2O) dissolved in 1000 ml of nanopure water. A  
100 ml aliquot was transferred and volume made up to 18 l with nanopure 
water. Final concentration was 0.91 mg Co/l. The solution was stored in clean 
plastic containers and kept refrigerated until used. The Co solution was 
delivered at 331 ml/d regulated by 0.64 mm inside diameter pump tube 
(Astoria Pacific International, Oregon, USA) supplying 0.3 mg Co/d. 
 
The total fructosan/sucrose mix was made up by dissolving 10 kg fructo-
oligosaccharide and 2 kg sucrose in hot water which was then made up to 18.5 l 
with distilled water. The daily soluble carbohydrate mix was delivered in 96 
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ml/h regulated by 1.65 mm inside diameter pump tube (Astoria Pacific 
International, Oregon, USA). Infusions of carbohydrate and urea were 
administered during the 4 h period from feeding of the hay to help simulate 
nutrient supply conditions of water soluble carbohydrate (WSC) in pastoral 
grazing situations. 
 
Polyethylene Glycol (PEG) 4000 was used as a liquid marker. The PEG 
infusion contained 30 g PEG/l (10 g PEG/animal/d) delivered at 331 ml/d 
regulated by 0.64 mm i.d pump tube (Astoria Pacific International, Oregon, 
USA). Infusion solutions were prepared by weighing 1.2 kg PEG 4000 into a  
40 l container which was then made up to volume with nanopure water. 
 
The urea solution was delivered in a volume to balance both diets for total 
liquid volume administered. The urea solution for the sheep on the barley 
based diet was made up by dissolving 470 g urea (Ravensdown Urea 46% N) in 
25 l water and delivered at the rate of 120 ml/h regulated by 1.85 mm inside 
diameter pump tube (Astoria Pacific International, Oregon, USA) administered 
during the 4 h period from feeding of the hay. The urea solution for the sheep 
on the sugar based diet was made up by dissolving 1.3 kg urea (Ravensdown 
Urea 46% N) in 6 l water and was delivered in 25 ml/h regulated by 0.89 mm 
i.d pump tube (Astoria Pacific International, Oregon, USA) administered 
during the 4 h period from feeding of the hay. 
 
A ChemLab CPP30 (England) peristaltic pump was used to drive all infusion 
lines. Actual volumes delivered were calculated by difference between volume 
before and after infusion. 
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 Plate 6.1: Example of the darkroom used to house infusates next door to experimental sheep. 
Infusion containers and lines were colour-coordinated for accuracy of recording and ease of 
detection of blocked or chewed lines. Green was urea solution; blue was PEG, black was sugar 
solution and red was cobalt solution.  
 
6.2.5  Sample analysis 
6.2.5.1 Abomasal vitamin B12 analysis 
Vitamin B12 in abomasal fluid was determined by chemiluminescence as 
previously described in Chapter 3.  
 
6.2.5.2 Abomasal PEG analysis 
Polyethylene glycol in abomasal fluid was determined by a modification of the 
turbidimetric method as previously described in Chapter 3.  
 
6.2.5.3 Ammonia analysis 
Acidified rumen samples were thawed, vortexed and accurately weighed (3-4 g) 
in duplicate into Kjeldahl tubes. Samples were inserted into Kjeltec Auto 1030 
Analyser (Tecator, Sweden) which automatically adds an excess of saturated 
sodium tetraborate (Na2B4O7), distils off the ammonia and titrates it against 
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0.03 molar hydrochloric acid (HCl). The volume titrated was converted to 
ammonia content (gNH3 N/kg rumen fluid). If duplicates differed by more 
than 5% the analysis was repeated.  
 
6.2.5.4 Fatty acid analysis 
Rumen samples were thawed and analysed for acetic, propionic, butyric, 
valeric and succinic acid concentrations as described in Chapter 3.  
 
6.2.6  Statistical analysis 
Analysis of variance was performed on vitamin B12 in plasma and abomasal 
fluid to determine significance of differences and possible interactions. All 
remaining measurements were analysed using repeated measures ANOVA to 
determine significance of difference and any possible interactions. Data were 
analysed using Genstat 5 (Release 4.21, Lawes Agricultural Trust, Rothamstead 
Experimental Station, 1997) and graphs plotted using Sigmaplot (Version 5.00, 
SPSS Inc, 1999).  
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6.3 Results 
6.3.1  Diet 
Analyses of the diet offered to each treatment group during infusion of sugar or 
continuation of the starch-enriched diet are given in Table 6.2. As an 
observation, animals on sugar-enriched diets generally consumed their feed at 
a much slower rate compared to their starch-enriched diet counterparts. One 
animal on the sugar-enriched diet developed acidosis and did not consume any 
feed. She was removed from the trial and subsequent statistical analysis. 
Table 6.2: Mean composition of starch- and sugar-enriched hay diets during the experimental 
period.  
 Hay 
(g) 
Barley 
(g) 
Urea 
(g) 
Fruct
-osan 
(g) 
Sucrose 
(g) 
aNDF*  
(g DM) 
ADF   
(g DM) 
MJ 
ME/  
 kg DM 
% 
sol. 
CHO 
Barley 
enriched diet 400 250 9 0 0 296 190 10.4 6 
Sugar 
enriched diet 
400 0 21.5 210 42 252 166 10.5 42 
*note NDF was determined for hay and aNDF was determined for the barley constituents of 
the diet.  
6.3.2  Digesta flow 
Calculated digesta liquid flow rates for each diet are given in Figure 6.1. 
Average digesta flow for barley and sugar enriched diets was 18.8 l/d and 14.4 
l/d respectively. There was a trend for higher digesta liquid flow on the barley 
diet (P=0.088) but no diet x time interaction (P=0.403). The overall mean was 
16.6 l/d.  
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Figure 6.1: Abomasal digesta liquid flow rates of ewes on a starch – (?), or sugar- (?), 
enriched diet during days 7 – 13 while receiving additional Co (0.3 mg Co/d intra-ruminally). 
Samples taken at 0800 h are linked by solid line. Samples linked by dashed line shows diurnal 
variation of additional samples taken at 1400 h, 2000 h and 0200 h.  
 
 
6.3.3 Rumen fermentation characteristics 
Mean rumen fluid acetic, propionic, butyric, valeric acid, ammonia 
concentration and pH during a 24 h sampling period on the starch and sugar 
enriched diets are given in Figure 6.2.  
 
Rumen pH was significantly affected by time (P<0.001), values dropping to 
lowest pH by 8 h after feeding before returning to initial values by 24 h. It was 
not affected by diet (P=0.164) nor was there a diet x time interaction 
(P=0.614).  
 
Valeric acid concentration was significantly affected by time (P<0.001) due to 
values rising to a peak after 6 – 8 h after feeding before subsequently returning 
 88
to initial values. There was no significant effect of diet (P=0.480) or diet x time 
interaction (P=0.720).  
 
Rumen ammonia concentration was affected significantly by time (P<0.001) 
but not by diet (P=0.231). There was a significant diet x time interaction 
(p<0.021), as a consequence of the sugar enriched diet causing a greater peak 
in rumen ammonia concentration after feeding despite having lower initial 
concentrations.  
 
Acetic acid concentrations were significantly affected by time (P<0.001) but 
there was no significant effect of diet (P=0.111) or diet x time interaction 
(P=0.072).  
 
Propionic acid concentrations were not affected by diet (P=0.230) and there 
was no diet x time interaction (P=0.527). A significant effect of time was 
identified (P<0.001) with rumen concentrations rising until 6 h after feeding 
before returning to initial values by 24 h after feeding.  
 
Butyric acid concentrations were not affected by diet (P=0.286), there was an 
effect of time (P=0.001) with rumen concentrations rising to a peak after 6 – 8 
h of feeding. There was, however, no significant diet x time interaction 
(P=0.089).  
 
Rumen succinic acid concentrations were not significantly affected by diet 
(P=0.138) nor was there any significant diet x time interaction (P=0.080) or 
effect of diet (P=0.138). There was an effect of time (P=0.024) with 
concentrations peaking at 2 and 4 hours after feeding for animals on starch 
and sugar diets respectively.  
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6.3.4  Vitamin B12 concentration in abomasal fluid 
Vitamin B12 concentrations in abomasal fluid during the 6-d infusion of 0.3 mg 
Co/d are given in Figure 6.3. There was a significant effect of time (P<0.001) 
on concentration but no significant effect of diet (P=0.494) or diet x time 
interaction (P=0.157). 
6.3.5  Vitamin B12 concentration in plasma 
Mean vitamin B12 concentrations in the plasma during the experimental period 
are given in Figure 6.4. Diet had no significant effect (P=0.737) on vitamin B12 
concentration whereas there was a significant effect of time (P<0.001). 
Vitamin B12 concentrations in plasma peaked at day 6 and declined to initial 
values by day 28. There was no significant diet x time interaction (P=0.494).  
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Figure 6.2: Mean rumen fluid acetic, propionic, butyric, succinic, valeric acid, ammonia 
concentration and pH during a 24 h period following the feeding of a starch (barley - ?), or 
sugar (fructose/sucrose mix - ?) enriched diets. 
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Figure 6.3: Vitamin B12 concentrations in abomasal fluid of sheep on a starch- (?), or 
sugar- (?) enriched diet while receiving intra-ruminal infusion of 0.3 mg Co/d during 
days 7-13. 
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Figure 6.4: Plasma vitamin B12 concentrations of sheep on a starch-(?) or sugar- (?) 
enriched diet during a 6-d intra-ruminal infusion of 0.3 mg Co/d. ▬ denotes period of infusion 
of Co solution, abomasal fluid sampling and digesta flow measurements. 
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6.4 Discussion 
The difference in the mean WSC content of the two diets used, mean 6% and 
42% WSC in the starch and sugar enriched diets respectively, encompassed the 
range of WSC content seen in practice, namely perennial ryegrass (Lolium 
perenne) cv Aberdart of 17% (Lovett et al., 2004) and white clover (Trifolium 
repens) at 8.4%, perennial ryegrass at 17% and cocksfoot (Dactylis glomerata) 
at 9% WSC (Mitchell, 1973). Thus, if the hypothesis of an effect of WSC on 
vitamin B12 production was correct, the range of WSC utilised would be 
expected to have affected vitamin B12 production.  
 
Closer examination of the digesta flow data suggests that since flow rates on 
day 7 were similar before Co infusions started, Co may have been responsible 
for the increase in digesta flow on starch enriched diets. The real question here 
is whether Co stimulated greater digesta flow. Starch-enriched diets did 
promote a higher average digesta flow (18.8 l/d) compared to the sugar-
enriched diet (14.4 l/d). While this difference was not statistically significant 
(P=0.088), the 30% difference in flow and trend lines does imply a difference. 
Some of the variation in digesta flow may be attributable to the difference in 
fibre content of the diets. The starch-enriched diet contained 16% more fibre 
which decreases digestibility and therefore could be expected to increase 
digesta flow (McDonald et al., 1995). However adjusting the sugar-enriched 
diet by 16% would only increase the digesta flow to 16.7 l/d, thus not 
accounting for all of the difference in digesta flow between the diets.  
 
If diet did cause a difference in digesta flow but no difference in abomasal 
concentration of vitamin B12, then diet did create a difference in vitamin B12 
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production as shown in Table 6.3. The production efficiency, regardless of diet, 
calculated with the present work is lower than that calculated in Chapter 5 on a 
similar Co intake of 0.26 mg Co/d which had a production efficiency of 2.43%. 
The major difference between the two Chapters is the maximum vitamin B12 
concentration in abomasal fluid. In Chapter 5, vitamin B12 concentration in 
abomasal fluid was double that in the present work although vitamin B12 
plasma concentration was of similar magnitude. It is difficult to explain this 
difference but one possible cause could have been the volume of infusates (120 
ml/h) administered in Chapter 6 for the 4 hr after feeding could have added 
significantly to abomasal flow, diluting abomasal liquid vitamin B12 
concentration. However the sampling method of 4 times a day during days 9-11 
would have accounted for any diurnal variation. Another possible cause for 
variation between trials is the higher concentration of PEG in digesta in the 
Chapter 6 (10 g/d as opposed to 2 g/d in Chapter 5) may have interfered with 
the measurement of vitamin B12 by chemiluminescence. There is no literature 
evidence that PEG interferes with chemiluminescence but this requires 
investigation. As a result of the lower vitamin B12 concentration in abomasal 
fluid in the present work, production efficiency is lower than expected and 
absorption coefficient is conversely higher as shown in Table 6.4.  
 
Table 6.3: Estimate of efficiency of vitamin B12 production after ruminal cobalt infusions of 
sheep consuming starch- or sugar- enriched diets. 
Diet Cobalt 
intake 
Theoretical 
maximum B12 
production* 
Maximum 
abomasal conc 
measured. 
Total abomasal 
B12 flow 
Production 
efficiency 
 (mg Co/d) (mg B12/d) (pmol/l) (mg B12/d) (%) 
Starch** 0.33 7.6 3343 0.085 1.12 
Sugar*** 0.33 7.6 3214 0.063 0.83 
*Assuming 100% incorporation of Co into vitamin B12 and that 100/4.35 mg vitamin B12/mg Co 
**Assuming digesta liquid flow of 18.8l/d 
***Assuming digesta liquid flow of 14.4 l/d 
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Table 6.4: Estimation of the absorption coefficient from vitamin B12 flow in the abomasum 
and plasma response from ruminal cobalt infusions and the equivalent plasma response from 
an intra-jugular vitamin B12 infusion of sheep consuming starch- or sugar- enriched diets.  
Diet Co intake 
(mg 
Co/d) 
Abomasal 
flow of 
vitamin B12 
(nmol/d) 
Plasma 
response 
(pmol/l) 
B12 infusion rate to give 
equivalent plasma 
response (nmol/d) 
(Chapter 4, Fig. 4.6) 
Absorption 
coefficient 
(%) 
Starch* 0.33 62.8 631 7 11 
Sugar** 0.33 46.3 703 9.4 20 
*Assuming digesta liquid flow of 18.8 l/d 
**Assuming digesta liquid flow of 14.4 l/d 
               
While production of vitamin B12 (nmol/d) appeared to be greater on the starch-
enriched diet, this was not translated into plasma concentration presumably as 
a consequence of lower absorption of the vitamin. Overall plasma 
concentrations were not significantly different whether the sheep received a 
starch or sugar-enriched diet. Clearly, this interpretation depends on the 
reliability of the digesta flow data.  
 
The level of Co infused was only 0.3 mg Co/d. The infusion level was kept low 
to ensure responsiveness to detect any different in vitamin B12 production or 
absorption, whilst preventing repletion and carry-over effects. The level of 
infusion may well have been better set between 0.5 – 0.6 mg Co/d to optimise 
vitamin B12 production (see Figures 5.5 and 5.6) which could possibly have 
magnified any potential difference caused by diet. On the other hand, earlier 
work has shown that efficiency of incorporation of Co into the vitamin 
decreases with increasing Co intake. 
 
Rumen pH was not affected by diet; therefore rumen stasis was not a probable 
cause of any potential difference in digesta flow between the diets. While every 
effort was made to balance both diets for total liquid volume administered, 
water intake from the troughs should have also been measured in an effort to 
account for the difference seen in liquid digesta flow. Also, total feed intakes 
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should have been more accurately measured. In previous experiments using 
these animals the diet was completely consumed, therefore was not considered 
to be a factor in the current experiment. However in the current experiment, an 
observation was made that animals on the sugar-enriched diet did eat their 
diet more slowly. Also compounding factors from prolonged deficiency may 
have had an effect. While sampling procedure should account for difference in 
rate of intake, the small quantity of hay left in the corners of the troughs could 
have had a significant effect on digesta flow.  
 
The degree of modification of rumen fermentation was limited. The higher 
succinic acid concentration of rumen fluid from sheep on the sugar-enriched 
diet raises the question as to whether conditions were optimal for its 
conversion to propionate. Conversion of succinate to propionate is a major 
metabolic pathway in rumen micro-organisms as shown in Figure 2.8 (page 
22) a pathway which is vitamin B12 dependent. The lack of difference between 
diets in vitamin B12 concentration in abomasal fluid suggests a lack of the 
vitamin was unlikely to be responsible. The type of carbohydrate supplied was 
limited in the extent to which it modified rumen fermentation between the two 
diets. There was no significant difference in any of the rumen concentrations of 
fatty acids measured during the 24 h sampling period. Moreover, while 
modification of rumen fermentation was limited, pH was not significantly 
different between diets. 
 
The infusion of highly fermentable carbohydrates meant that acidosis was a 
consideration. The adjustment period should perhaps have been extended 
from 7 days to 10-14 days to allow rumen micro-organisms more time to 
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adjust. It was considered 7 days would be long enough adjustment due to the 
animals having already been fed 250 g of crushed barley for several months. 
However one animal had to be with drawn from the trial in the first treatment 
and the replacement animal proved not to be deficient in vitamin B12 so was 
also withdrawn from the analysis of data.  
 
Anecdotal evidence that dietary factors other than Co affect vitamin B12 
production and/or absorption originates from long term trials conducted in 
Norway during the 1980’s. In the trials lambs were grazed for an average of 143 
days each year on ovine white liver disease (OWLD) pastures (S) and 15 km 
away on control (H) pasture (Ulvund & Pestalozzi, 1990a). These authors 
suggested a factor other than pasture Co levels may influence the development 
of OWLD. The pastures where the disease occurred (S) were dominated by 
perennial ryegrass and were high in water soluble carbohydrates (WSC), 
particularly fructans. Lambs grazing H pastures gained an average 10 kg more 
over the 5 month period and cobalt levels were actually higher on the S pasture 
at 0.024, 0.134 and 0.046 mg Co/kg DM at weeks 21, 26 and 32 respectively 
compared to H pastures which contained 0.020, 0.023 and 0.047 mg Co/kg 
DM, at the same time intervals. However the massive increase of Co 
concentration in the second pasture sample only 5 weeks later on S pastures 
would suggest soil contamination due to much higher levels in the soil than the 
pasture (Grace, 1994). Ulvund & Pestalozzi, (1990b) suggested the higher levels 
of fructans for the month of June on S pastures may have initiated 
methylmalonyl CoA mutase overload leading to hepatic lipid abnormality, 
growth retardation and the development of OWLD. The levels of fructans at the 
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start of June when lambs started to active graze the pasture were 12.9 g/kg ww 
on S pastures as opposed to 7.3 g/kg ww on H pastures.  
 
Although differences were noticed between treatment groups by the latter 
authors, pasture species and soil acidity were different among the pastures. S 
pastures were dominated by Poa spp. (meadow grass), Agropyron repens 
(Twitch grass) and Lolium perenne (perennial ryegrass), while H pastures were 
dominated by Poa spp., Festuca rubra (red fescue) and Agrostis tenuis (brown 
top). Soils were more acidic on the H pastures which does increase the uptake 
of Co by plants (Grace, 1994). This may help explain the differences seen. 
 
The results of the present chapter do add some support to the anecdotal 
evidence of Ulvund (1990b) that a diet high in WSC may retard production of 
vitamin B12, or at least, prevents additional production in the presence of 
increased ruminal Co concentration. While the sugar enriched diet did tend to 
provide lower digesta flow than barley enriched diet, it was not statistically 
significant. However, any difference in production appears to have been 
masked by a possible reduction in absorption of vitamin B12, as discussed in 
the previous Chapter. As a result, no difference was detected in plasma vitamin 
B12 concentration between the diets. While the two diets differed highly in WSC 
content, rumen fermentation characteristics were not significantly modified 
between diets. This demonstrated the robust buffering effect of rumen micro-
organisms to resist modification of fermentation. Had the diets produced 
significant changes in fermentation, differences in vitamin B12 production 
and/or absorption may have been detected. 
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CHAPTER 7: General Discussion 
The validity of the depletion – repletion technique described within the present 
research is dependent on the assumption that vitamin B12 infused directly into 
the bloodstream behaves biologically identically to naturally absorbed vitamin. 
While this assumption can not be validated without measurement of transport 
proteins, the general trends in disappearance from the plasma were similar 
regardless of mode of entry into the bloodstream.  
 
It was also observed that there was between animal variation in response to 
intra-venous infusion of vitamin B12. It has been suggested in earlier discussion 
that tissue concentration of vitamin B12 may have an effect in moderating the 
size of response in plasma vitamin B12 to a change in vitamin B12 absorption. 
Since liver samples could not be obtained as had been planned, it was not 
possible to test this hypothesis. Gruner, et al. (2004b) did, however, observe 
variation in plasma response to vitamin B12 injection in lambs suckling Co 
supplemented and unsupplemented mother. The former had larger plasma 
responses to supplementation with vitamin B12 than lambs from 
unsupplemented mothers even though their pre-injection plasma 
concentration of the vitamin was identical. This suggests that plasma 
responses to entry of the vitamin into the bloodstream may be dependent on 
tissue concentration. This suggests that rate of transfer of vitamin B12 to tissues 
is inversely related to tissue concentration with the result that vitamin B12 
accumulates in plasma to a greater degree as tissues replete. This theory is 
depicted pictorially in Figure 7.1. 
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 Figure 7.1: Schematic representation of the relationship between tissue and plasma pools of 
vitamin B12. Animals with low tissue concentration before supplementation (A), have a lower 
plasma response than animals with a higher tissue concentration before supplementation (B), 
even though initial plasma concentrations are the same.  
 
Thus, two plausible explanations may be involved in the regulation of plasma 
vitamin B12 concentration. Firstly, logically, for a microbially synthesised 
vitamin, production may be regulated by microbial activity determined by the 
amount of fermentable material entering the GIT. Secondly, plasma 
concentration response may be influenced by interplay between rates of 
appearance and disappearance of the vitamin into and from the plasma pool, 
with the latter, as tissues become more replete resulting in greater 
accumulation in the plasma.   
 
The schematic representation presented in Figure 7.1 may also help explain the 
difference plasma response between trials. The mean plasma vitamin B12 
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baseline drifted from 300-400 pmol/l in Chapter 4 to 200pmol/l in Chapter 6. 
Sheep would have been more Co deficient in the last than in the preceding 
trials and, as a result, the data may not have been directly comparable between 
trials.  
 
There is also an issue of potential differences in digesta flow between Chapter 5 
and 6. Overall means for each Chapter were compared in a two-sample t-test. 
The digesta flow used in Chapter 5 (14.6 l/d) was significantly different 
(P<0.001) to the digesta flow determined in Chapter 6 (16.6 l/d). This 
difference raises an important issue. The average flow rate used in Chapter 5 
was 14.6 l/d, very similar to the rates observed in Chapter 6 on the sugar-
enriched diet of 14.4 l/d but lower than 18.8 l/d on the starch-enriched diet. 
The starch-enriched diet was, however, the same as that used in Chapter 5 and 
similar flow rates would have been anticipated. However, one difference was 
that sheep used in earlier trial were not receiving the additional Co via infusion 
at the time of digesta flow measurements. It is interesting that the animals 
receiving the starch-enriched diet in Chapter 6 showed a trend for increase in 
flow rate on the commencement of infusion of Co. Therefore it may be that the 
addition of infused Co on a starch-enriched diet could have increased digesta 
flow through the abomasum or alternatively, this undermines the confidence of 
using the digesta flows used in Chapter 5 in calculating production and 
absorption efficiencies.  The digesta flow rates from Chapter 6 can be applied 
retrospectively to Chapter 5 data (see Tables 7.1 and 7.2). Clearly in light of this 
information, digesta flow rates need to be calculated on sheep during infusion 
of additional Co to account for any such difference in digesta flow that 
infusions may cause. This is done in Table 7.1, which suggests a starch-
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enriched diet may promote greater rates of production and therefore efficiency 
of production of vitamin B12.   
 
Table 7.1: Estimate of efficiency of vitamin B12 production after ruminal cobalt infusions used 
in Chapter 5, table 5.4, retrospectively using adjusted digesta flow data. 
 
Cobalt 
intake  
(mg 
Co/d) 
Theoretical 
maximum 
B12 
production* 
(mg B12/d) 
Maximum 
abomasal 
conc 
measured 
(pmol/l) 
Total 
abomasal 
B12 flow 
barley 
diet** 
(mg B12/d) 
Total 
abomasal 
B12 flow 
sugar 
diet*** 
(mg B12/d) 
Production 
efficiency 
barley diet 
(%) 
Production 
efficiency 
sugar diet 
(%) 
Production 
efficiency 
(%) (from 
Table 5.4) 
0.03 0.69 2277 0.058 0.044 8.41 6.48 6.52 
0.26 6.0 7376 0.188 0.144 3.13 2.40 2.43 
0.67 15.4 8682 0.221 0.169 1.44 1.10 1.12 
1.11 25.5 9706 0.247 0.189 0.97 0.74 0.75 
*Assuming 100% incorporation of Co into vitamin B12 and that 100/4.35 mg vitamin B12/mg Co 
**Assuming digesta liquid flow of 18.8 l/d 
***Assuming digesta liquid flow of 14.4 l/d 
 
 
The method of estimating production efficiency relies heavily on the accuracy 
of the digesta flow measurement. With the data presented, production 
efficiency appears to be between 6.5% and 8.4% on a Co intake of 0.03 mg /d 
and between 0.74 and 0.97% on higher Co intake of 1.11 mg / d.  
 
Table 7.2: Estimation of the absorption coefficient for vitamin B12 from flow of the vitamin in 
the abomasum and plasma response from ruminal cobalt infusions used in Chapter 5, table 5.5 
and the equivalent plasma response from an intra-jugular vitamin B12 infusion.  
 
Co 
intake 
(mg 
Co/d) 
Abomasal 
flow of B12 
barley diet * 
(nmol/d) 
Abomasal 
flow of B12 
sugar diet ** 
(nmol/d) 
Plasma 
response 
(pmol/l) 
B12 infusion rate 
to give equivalent 
plasma response 
(nmol/d) (Figure 
4.6) 
Absorption 
coefficient 
barley diet 
(%) 
Absorption 
coefficient 
sugar diet 
(%) 
Absorption 
coefficient 
(%) from 
Table 
5.5*** 
0.03 42.8 32.8 248 - - - - 
0.26 139 106 640 7.3 5.3 6.9 6.8 
0.67 163 125 748 10.9 6.7 8.7 8.7 
1.11 182 140 833 14.1 7.7 10.1 9.9 
* Assuming liquid digesta flow rate of 18.8 l/d 
** Assuming liquid digesta flow rate of 14.4 l/d 
*** Assuming liquid digesta flow rate of 14.6 l/d 
 
Absorption of vitamin B12 appears to increase with increasing Co intake, 
although its precise value depends on the accuracy of digesta flow 
measurements. Based on a digesta flow of 18.8 l/d, absorption increases from 
5.3 to 7.7% as Co intake increases from 0.26 to 1.11 mg Co/d. Based on slower 
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digesta flow rate of 14.4 l/d, absorption is higher at 6.9-10.1% as Co intake 
increases from 0.26 to 1.11 mg Co/d.  
 
While production of vitamin B12 appeared to be greater on a starch-enriched 
diet, any difference in the plasma was eroded by a lower absorption of the 
vitamin. Overall plasma concentrations were not significantly different 
whether the sheep received a starch or sugar-enriched diet.  
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CHAPTER 8: General Summary 
 
The current animal model developed within this thesis is capable of 
determining which factors affect vitamin B12 production and/or absorption. A 
similar approach was made to that of Suttle’s (1974) method of Cu repletion 
and appears quantitatively robust. Plasma responses have been calibrated with 
direct infusions of known amounts of vitamin B12 into the bloodstream. 
Vitamin B12 flows past the abomasum have been estimated to obtain 
measurements of total vitamin B12 available for absorption and related to the 
amount appearing in the plasma for estimates of absorption coefficient. Plasma 
vitamin B12 responses have also been measured in terms of how much dietary 
Co it took to obtain that response. Calibrating response from dietary Co also 
adds strength to the model by enabling an estimate of production efficiency of 
vitamin B12 in the rumen from daily Co intake compared to abomasal vitamin 
B12 flow.  
 
Further information is needed on the distribution and excretion of vitamin B12 
within the bloodstream. The amount of vitamin B12 appearing in the extra 
cellular space has been estimated between 7-13% of the infused vitamin B12 
once response has reached a plateau. The fate of the other 87-93% of the 
infused vitamin B12 which was absorbed into the tissues or excreted still needs 
to be clarified. Also more robust digesta flow data needs to be measured due to 
its influence on subsequent vitamin B12 production and absorption 
calculations.  
 
Future trials which would help validate this model would investigate whether 
tissue status of the animal affects its plasma response to supplementation. For 
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example, do long-term deficient animals with low plasma and low liver vitamin 
B12 levels respond differently to more recently depleted animals with low 
plasma but higher liver vitamin B12 levels? Clearly, if tissue analysis of vitamin 
B12 was available in the current research, a more comprehensive understanding 
of vitamin B12 metabolism could have been made.  
 
Production efficiency has been demonstrated to be low; decreasing from 8.4% 
to 0.74% as Co intake increases from 0.03 to 1.11 mg Co/d. However, there was 
evidence which suggested that as digesta flow increases, production efficiency 
may also increased. These efficiencies are lower than previous estimates 
(Smith & Marston, 1970) although similar in trend of decreasing efficiency as 
Co intake increases.  
 
Absorption efficiency was estimated by the ratio of total abomasal vitamin B12 
flow to the quantified plasma response. Absorption efficiency was observed to 
increase from 7 to 10% as abomasal vitamin B12 flow increased from 108 to 142 
nmol B12/d. These estimates are less variable than previous research (Elliot et 
al., 1971) and higher than Marston’s (1970) estimate of 3%.  
 
The model was used to investigate the observation from the literature that the 
carbohydrate source in the diet may affect vitamin B12 production and/or 
absorption. There was some evidence that when sheep were offered a high 
starch diet, via barley, and infused with additional Co, flow of the vitamin from 
the rumen may be 30% greater than in sheep on a high water soluble 
carbohydrate diet. This did not, however, translate into higher plasma 
concentrations of the vitamin.  
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Appendix A  Feed Analysis 
Soluble carbohydrates 
Soluble carbohydrates were extracted in water and determined 
spectrophotometrically as the green-blue complex formed when carbohydrates 
are heated with anthrone in sulphuric acid. Herbage samples were frozen at  
-20oC overnight and then freeze-dried and passed through a Retsch ZM100 
centrifugal mill with a 1 mm sieve. Samples (0.2 g in duplicate) were placed in 
a plastic 250 ml wide mouth, screw cap bottle and 200 ml nanopure water 
added. The bottle was capped and shaken for 1 h at approximately 275 
strokes/min on a Labline orbital shaker, model 4628-1. Samples were filtered 
through a No. 1 Whatman filter paper, the first few millilitres were rejected to 
eliminate any cloudy residue from the filter paper and the remainder collected. 
Determination was carried out within 1 h of filtration. Anthrone reagent (760 
ml of nitrogen free sulphuric acid) was added slowly with constant stirring to 
330 ml H2O and cooled rapidly. Thiourea (1 g) and anthrone (1 g) was added 
and the mixture stirred. Glucose was used as a standard – 0.8 mg/ml D-
glucose (0.4 g/500 ml). Standard aliquots were 0, 0.04, 0.08, 0.12, 0.16 and 
0.20 mg glucose/ml. Standard or extract (2 g) was placed in a glass test tube 
(150 x 25 mm) and cooled on ice for 10 min. With the test tube held on an 
angle in the ice, 10 ml of anthrone reagent was added slowly so it ran down the 
side of the tube and formed a layer under the solution. With the tube still on 
ice, the contents were gently mixed and the temperature maintained below 
25oC. Each tube was loosely stopped and placed in a boiling water bath for 
exactly 20 min. Tubes were then removed and placed on ice to reduce to 
ambient temperature as rapidly as possible. Absorbance was measured in a 10 
mm cell at 620 nm within 30 min.  
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In-vitro digestibility  
Sintered glass crucibles were oven dried (105oC) overnight. Duplicate 0.500 ± 
0.001 g, samples of the feed, which had been ground through a 1.0 mm sieve 
were placed in pre-weighed crucibles. A rubber stopper was securely fitted to 
the base of the crucible. Pepsin solution (30 ml of 0.3% w/v in 0.125% HCl) 
was added to the top of the crucible and the crucible capped and incubated at 
50oC for 68 h. Samples were removed and pepsin solution filtered off under 
low vacuum and the crucible rinsed with 2 x 10 ml aliquots of hot nanopure 
water, filtered and rinsed with another 10 ml aliquot of water. Cellulase 
solution (30 ml of 0.025 g cellulase per 0.5 g sample) was added to each 
crucible, the crucible recapped and the contents digested at 50oC for 48 h. 
Samples were removed and cellulase solution filtered off under low vacuum 
and rinsed with 2 x 10 ml aliquot hot nanopure water, filtered and then washed 
with another 10 ml aliquot of water. Crucibles were dried at 105oC overnight 
and weighed from a desiccator when cool. Crucibles were ashed at 500oC for 6-
8 h and re-weighed from a desiccator when cool. Cellulase Organic Matter 
Digestibility % (% Cellulase OMD) and cellulase Dry Matter Digestibility (% 
Cellulose DMD) was calculated using initial and residual dry ash weights, dry 
weight proportion and sample weight. Predicted % in-vitro digestibility on a 
dry matter basis was calculated by 6.70 + (0.902 x % Cellulase DMD), and on 
an organic basis by 2.81 + (1.03 x % Cellulase OMD). 
Detergent fibre analysis 
Feed samples were freeze-dried and ground through a 1.0 mm sieve. 
Approximately 1 g was accurately weighed into 400 ml beakers in duplicate. 
Respective reagent was added (50 ml) depending on analysis and the beaker 
was placed on hotplate with refluxing condensers assembled over the top of the 
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beaker. The samples were brought to the boil and simmered for 1 h. For aNDF 
analysis, an additional 2 ml of standardised amylase solution was added once 
samples were boiling. Heating was stopped and cooled samples were filtered 
through pre-weighed crucibles, rinsed with boiling water under vacuum until 
bubbles ran clear and rinsed twice with acetone to remove water. Crucibles 
were then placed in an oven at 105oC overnight and re-weighed the next day 
once they had cooled in the desiccator. The crucibles were then place in the 
furnace at 500oC for 2 h, cooled and ash weight recorded. Respective detergent 
fibre percent was calculated by dry fibre weight divided by initial sample 
weight dry matter multiplied by 100.  
 Cobalt content 
Samples were mixed, spread evenly in trays and divided into quarters. One 
quarter was placed into a drying bag and maintained at 65oC overnight which 
samples typically retained 5% moisture. The remainder of the sample was 
returned to the original bag for future analysis if needed. Dried samples were 
passed through a Tecator Cyclotec self-cleaning mill with a 0.5 mm screen. A 
0.200 g sample of ground plant material was placed in 40 ml digestion tubes 
along with 3-5 glass beads. Digestion acid, 3 ml (nitric-perchloric digestion 
acid, 2:1 mix of nitric acid (HNO3, MW 63, 69-70.5%) and perchloric acid 
(HClO4, MW 100.5, 70%)) was added to each tube and vortexed. Tubes were 
placed on a 100oC pre-heated digestion block where they were heated for 2.55 
h using a temperature ramp up to 205oC (Figure 3.1). Once completed, the 
digestion block was allowed to cool to approximately 80oC when 19.2 ml of 
water was added to each tube. Tubes were then placed back on the digestion 
block at 80oC for 10 min. While solutions were hot, each tube was vortexed 
thoroughly 3 times and allowed to cool for 30 min. For Co analysis, 2.5 ml 
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aliquots of digests were placed into the appropriate tubes along with 2.5 ml 
solution of nitric acid (1% v/v) and vortexed. Samples were analysed by 
Inductively Coupled Plasma Mass Spectrometer (ICP-MS). 
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Figure 9.1: Temperature Profile for Basic Plant Digestion Analysis of Co 
 
Tissue & digesta sample preparation and analysis 
Vitamin B12 in plasma samples 
All samples were pre-treated to denature any carrier proteins. Plasma samples 
(200 µl), controls or a blank sample of 0.9% (w/v) saline solution were 
pipetted into 5 ml polypropylene tubes. Working solution was prepared on a 
daily basis (mixture of 1000 µl Borate-KCN Buffer Solution and 20 µl 
Dithiothreitol Solution per test) and 1000 µl added to each tube and vortex. All 
tubes were covered with foil and placed in a covered boiling water bath at 
100oC for 20 min. Tubes were then removed and cooled in an ambient water 
bath for 5 min and then capped. At least 350 µl of treated sample was pipetted 
to a sample cup. Assay was performed by IMMULITE Chemiluminescence 
Immunoassay System. This system introduces samples an hog intrinsic factor 
into a test unit containing polystyrene beads coated with vitamin B12 analogue. 
During an incubation period, sample vitamin B12 competes for the limited 
number of binding sites with the vitamin B12 analogue. Alkaline phosphatase-
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labelled anti-hog intrinsic factor is added and binds unbound intrinsic factor, 
which is then removed by centrifugal wash. The IMMULITE vitamin B12 
procedure has a calibration range of 74 to 885 ρmol/L. Samples expected or 
found to be above this range were diluted with 0.9% (w/v) saline solution 
before assay.  
Vitamin B12 in abomasal digesta 
Samples were pre-diluted with ovine albumin matrix depending on 
concentration to obtain measured values below 850 pmol/l. A blank ovine 
albumin matrix sample was also measured as a background measure and 
subtracted from results if needed. All samples subsequently followed the same 
treatment as described for vitamin B12 in plasma samples, taking into account 
any dilution factor used.   
Digesta marker concentration 
Abomasal samples were centrifuged for 30 min at 28 000 g in a JA-20 rotor to 
separate particulate matter. In the work described in Chapter 4, the 
supernatant was clarified with ZnSO4 and Ba(OH)2 as described by Smith, 
(1959). Samples of 3 ml supernatant were pipetted into 50 ml centrifuge tubes, 
to which 2 ml of 4.73% (w/v) Ba(OH)2.8H2O was added followed by 2 ml 5% 
(w/v) ZnSO4.7H2O. The concentrations of the Ba(OH)2.8H20 and ZnSO4.7H2O 
solutions were measured previously to give molar solutions and neutralisation 
of the alkali against the zinc sulphate (Somogyi, 1945).To this, 0.5 ml of 10% 
(w/v) BaCl2.2H2O was added and mixture made up to 10 ml with nanopure 
water and shaken well. Samples were centrifuged at 15 000 g for 10 min.  
 
Depending on PEG concentration, 0.5 to 5 ml of the resulting supernatant was 
pipetted into 15 ml test tubes and made up to 5 ml with nanopure water. PEG 
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turbidity was achieved by adding 5 ml of an aqueous solution of 30% (w/v) 
trichloroacetate acid (TCA) and 5.9% (w/v) BaCl2.2H2O to each test tube.  
 
Tubes were left to stand for 60 min before the solution was transferred into 
disposable 4 ml curvettes, wavelength 340 – 800 ηm (Biolab Ltd, Auckland, 
New Zealand) and transmittance read by Perkin-Elmer spectrophotometer at 
525 mμ. If duplicates differed in transmittance by more than 3%, the analysis 
was repeated. PEG standard solutions were prepared by accurately measuring 
0, 0.25, 0.5, 1 and 1.5 g PEG into 100 ml volumetric flask (A) and made to 
volume with nanopure water. An aliquot of 1 ml was taken from respective 
samples and placed in a recipient 100 ml volumetric flask (B) and made to 
volume with nanopure water to achieve a 1:100 dilution.  
 
The following adaptations were made for PEG analysis described in Chapter 6. 
Abomasal samples were centrifuged for 30 min at 28 000 g in a JA-20 rotor to 
separate particulate matter. Samples of 3 ml supernatant were pipetted into a 
50 ml centrifuge tubes, clarified with 5 ml of 0.038 mol ZnSO4 and 5 ml of 
0.038 mol Ba(OH)2 The concentrations of the Ba(OH)2.8H20 and ZnSO4.7H2O 
solutions were measured previously to give molar solutions and neutralise the 
alkali against the zinc sulphate (Somogyi, 1945). To this, 0.5 ml of 10% (w/v) 
BaCl2.2H2O was added and 0.5 ml H2O and shaken well. Samples were left to 
stand for 10 min and then centrifuged at 15 000 g for 10 min.  
 
The resulting supernatant (2 ml) was pipetted into 15 ml test tubes and 3 ml of 
0.4 mg/ml Gum Arabic (Malawer & Powell, 1967) added. PEG turbidity was 
achieved by adding 5 ml of a pre-filtered (0.45 µm cellulose nitrate membrane) 
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aqueous solution of 30% (w/v) trichloroacetate acid (TCA) and 5.9% (w/v) 
BaCl2.2H2O into each test tube. The tubes were left to stand for 60 min before 
the solution was transferred into disposable 4 ml curvettes, wavelength 340 – 
800 ηm (Biolab Ltd, Auckland, New Zealand) and transmittance read by 
Perkin-Elmer spectrophotometer at 340 mμ. If duplicates differed by more 
than 3% transmittance, the analysis was repeated. Standard tubes were 
prepared using 2.7 ml blank abomasal fluid and a 300 µl spike of 6, 9, 12 and 
15 mg PEG/ml to give final concentrations of 0, 0.6, 0.9, 1.2 and 1.5 mg 
PEG/ml of original sample.  
 Fatty acid analysis 
Rumen samples for fatty acid (FA) analysis were thawed and centrifuged at 
28000 g for 30 min at 4oC. A 500 μl aliquot of the supernatant was mixed with 
500 μl internal standard (10 mmol of 2-methylvaleric acid in 100 ml nanopure 
H20) in a 1.5 ml micro-centrifuge tube. The final concentration of the internal 
standard was 5 mmol/l. Samples were vortexed then filtered through a  
0.22 μm PES millipore syringe driven filter (Millex Corporation Bedford, USA) 
into pre-labelled autosampler tubes. Acetic, propionic, butyric, valeric and 
succinic acid concentrations were determined by Gas Chromatography using a 
Hewlett Packard (HP) 6890 GC with HP ChemStation software, version 
A.03.04. A 5 μl aliquot of sample was injected onto the column (HP-INNOWax 
polyethylene glycol 30.0 m x 250 μm x 0.25 μm capillary column) using a 20:1 
split injection. The oven was kept at an initial temperature of 85oC for two min 
then ramped at 10oC/min to a final temperature of 200oC. Run time was  
23.5 min; post run temperature was 50oC and was held for 5 min. Helium was 
used as the carrier gas at a pressure of 156.9 kPa to give a flow rate of  
2.0 ml/min. The inlet liner (SGE, Australia) was replaced after approximately 
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40 samples to prevent constriction of sample delivery onto the column, in line 
with good laboratory practice.  
 
At the beginning and end of each analytical run, sets of external calibration 
standards were run to produce linear calibration curves in the range required 
for quantification of FA’s present. The succinic acid standard curve was 
extended to cover the low concentrations found. Concentrations between 0.6 
and 1.0 mmol/l were added to the final calibration curve to produce a 
representative linear graph. An external standard solution was prepared by 
mixing a FA solution containing 100 mmol of acetic and propionic, 50 mmol of 
butyric and succinic, 25 mmol valeric made up to volume in 100 ml nanopure 
H20. This external standard solution (500, 300, 200, 100, 50 μl) was mixed 
with 500 μl internal standard and made up to 1000 μl with nanopure H20 into 
a 1.5 ml micro-centrifuge tube. This gave external standards at their final 
concentration of 50, 30, 20, 10 and 5% respectively of the original external 
standard solution. Standards then followed the same protocol as mixed rumen 
samples above.  
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Appendix B - Example calculation of vitamin B12 
production efficiency 
 
Cobalt intake     0.03 mg/d /    0.0435 (4.35% Co/ B12 molecule) 
= 0.69 mg B12/d (Theoretical maximum B12 production assuming 
100% incorporation of Co into B12).  
 
Need to convert maximum abomasal concentration into the same units as 
theoretical maximum production.  
 
Abomasal conc.      2277 pmol/d        x        14.6 l/d 
   = 33 244 pmol/d 
   = 33.244 nmol/d    x    1355 ng/nM   (molecular weight of B12) 
   = 45 046 ng/d 
   = 0.045 mg B12/d 
 
Production efficiency  =  abomasal flow  /  theoretical maximum 
   = 0.045/0.69        x       100 = 6.52% 
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Appendix C – Example calculation of vitamin B12 
absorption coefficient 
 
From Chapter 5, cobalt intake of 0.26 mg Co/d equated to abomasal vitamin 
B12 concentration of 7376 pmol/l (Table 5.4). Multiplied by digesta flow rate of 
14.6 l/d equates to an abomasal flow of vitamin B12 of 108 nmol B12/d.  
 
Using the relationship described in Figure 5.7, an abomasal flow of 108 nmol 
B12/d equates to a plasma vitamin B12 responses of 640 pmol/l 
 
Using the quantified response in Chapter 4, Figure 4.6 a plasma response of 
640 pmol/l required an intra-jugular infusion of 7.3 nmol/d.  
 
Absorption coefficient is the ratio of the quantity of B12 in the bloodstream 
divided by the total available for absorption (i.e. abomasal flow). Therefore, 
 7.3 / 108  x  100 = 6.8% absorption 
